RxNorm Semantic Concepts Index - 262
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "262".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 262 | Actin-binding protein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 262 | Actin-binding protein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2620 | clotiapine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2620 | clotiapine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2620 | clotiapine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2620 | clotiapine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2620178 | MPEG 6000 acetyl lysine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2620179 | vat violet 2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 262063 | VALSTAR 200 MG per 5 ML (40 MG/ML) Irrigation Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 262063 | VALSTAR 200 MG per 5 ML (40 MG/ML) Irrigation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 262063 | VALSTAR 200 MG per 5 ML (40 MG/ML) Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 262063 | VALSTAR 200 MG per 5 ML (40 MG/ML) Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2620668 | Amisulpride 50 mg orodispersible tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2620668 | Amisulpride 50 mg orodispersible tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 262071 | DURAGESIC 100 MCG/HR 72HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 262071 | DURAGESIC 100 MCG/HR 72HR Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 262071 | DURAGESIC 100 MCG/HR 72HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 262071 | DURAGESIC 100 MCG/HR 72HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 262071 | DURAGESIC 100 MCG/HR 72HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 262071 | DURAGESIC 100 MCG/HR 72HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 262072 | 24 HR testosterone 0.25 MG/HR Transdermal System [Testoderm] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 262072 | 24 HR testosterone 0.25 MG/HR Transdermal System [Testoderm] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 262072 | 24 HR testosterone 0.25 MG/HR Transdermal System [Testoderm] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 262072 | 24 HR testosterone 0.25 MG/HR Transdermal System [Testoderm] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 262073 | amoxicillin 40 MG/ML Oral Suspension [Amoxil] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 262073 | amoxicillin 40 MG/ML Oral Suspension [Amoxil] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 262073 | amoxicillin 40 MG/ML Oral Suspension [Amoxil] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 262077 | RisperDAL 0.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 262077 | RisperDAL 0.25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 262077 | RisperDAL 0.25 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 262077 | RisperDAL 0.25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 262077 | RisperDAL 0.25 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 262080 | Prometrium 100 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 262080 | Prometrium 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 262080 | Prometrium 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2620843 | polyamide-5 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 262085 | gatifloxacin 200 MG Oral Tablet [Tequin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 262085 | gatifloxacin 200 MG Oral Tablet [Tequin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 262090 | Trileptal 600 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 262090 | Trileptal 600 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 262090 | Trileptal 600 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 262090 | Trileptal 600 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 262091 | Zyvox 600 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 262091 | Zyvox 600 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 262091 | Zyvox 600 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 262095 | Lipitor 80 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 262095 | Lipitor 80 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 262095 | Lipitor 80 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 262095 | Lipitor 80 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 262099 | Product containing phenazopyridine and sulfamethoxazole (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 262099 | Product containing phenazopyridine and sulfamethoxazole (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 262099 | Product containing phenazopyridine and sulfamethoxazole (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 262100 | rapacuronium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 262100 | rapacuronium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 262100 | rapacuronium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 262100 | rapacuronium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 262100 | rapacuronium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2621019 | linzagolix | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2621020 | linzagolix choline | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2621021 | furosemide Cartridge | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2621022 | furosemide 80 MG in 10 ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2621022 | furosemide 80 MG in 10 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621022 | furosemide 80 MG in 10 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2621022 | furosemide 80 MG in 10 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621023 | furosemide 8 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2621024 | Furoscix | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2621025 | furosemide 8 MG/ML [Furoscix] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2621026 | Furoscix Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2621027 | furosemide Cartridge [Furoscix] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2621028 | Furoscix 80 MG in 10 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621028 | Furoscix 80 MG in 10 ML Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2621028 | Furoscix 80 MG in 10 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621028 | Furoscix 80 MG in 10 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2621028 | Furoscix 80 MG in 10 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621029 | furosemide 8 MG/ML Cartridge [Furoscix] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2621029 | furosemide 8 MG/ML Cartridge [Furoscix] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 262103 | Antagon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 262105 | Aromasin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 262110 | Chloraseptic Spray | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2621118 | Pinus radiata bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2621119 | PPG-10 caprylyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 262112 | Comtan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2621121 | vat yellow 4 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2621122 | acid red 337 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2621123 | levothyroxine sodium 100 MCG in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2621123 | levothyroxine sodium 100 MCG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2621123 | levothyroxine sodium 100 MCG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 262115 | Derma-Pax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 262119 | Fe 50 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 262120 | Ferate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2621209 | Sparassis crispa fruiting body extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2621210 | propanediol caprylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2621214 | Firox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2621215 | firocoxib 57 MG [Firox] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2621216 | Firox Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2621217 | Firox Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2621218 | Firox Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2621219 | firocoxib Chewable Tablet [Firox] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2621220 | Firox 57 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2621220 | Firox 57 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2621220 | Firox 57 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2621221 | firocoxib 227 MG [Firox] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2621222 | Firox 227 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2621222 | Firox 227 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2621222 | Firox 227 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 262123 | Icar | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2621236 | sapropterin dihydrochloride 500 MG [Javygtor] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2621237 | JAVYGTOR 500 MG Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2621237 | JAVYGTOR 500 MG Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621237 | JAVYGTOR 500 MG Powder for Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2621251 | menthol 0.0044 MG/MG / zinc oxide 0.206 MG/MG [Risamine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2621252 | Risamine 0.44 % / 20.6 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2621252 | Risamine 0.44 % / 20.6 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621252 | Risamine 0.44 % / 20.6 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621252 | Risamine 0.44 % / 20.6 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 262128 | Nascobal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2621349 | citicoline 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2621349 | citicoline 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 262135 | Penlac Nail Lacquer | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2621353 | mecobalamin 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2621354 | mecobalamin 2500 MCG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2621354 | mecobalamin 2500 MCG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2621354 | mecobalamin 2500 MCG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621357 | edetate calcium disodium 500 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2621357 | edetate calcium disodium 500 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2621357 | edetate calcium disodium 500 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621358 | edetate calcium disodium 50 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 262136 | Pentopak | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 262138 | Precedex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2621385 | Syzygium luehmannii fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2621389 | edetate calcium disodium 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 262139 | Priftin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 262140 | Prometrium | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 262144 | Retre-Gel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 262145 | Ryna-12 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 262148 | Tussi-12 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 262149 | Vioxx | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 262150 | Iron carbonyl | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 262150 | Iron carbonyl | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 262150 | Iron carbonyl | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 262150 | Iron carbonyl | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 262150 | Iron carbonyl | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2621544 | polyglyceryl-2 distearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2621545 | Rosa centifolia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2621546 | 1,2-distearoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2621547 | silver stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2621548 | mirvetuximab soravtansine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2621549 | mirvetuximab soravtansine-gynx | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2621550 | mirvetuximab soravtansine-gynx 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2621551 | mirvetuximab soravtansine Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2621552 | mirvetuximab soravtansine Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2621553 | mirvetuximab soravtansine-gynx 100 MG in 20 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2621553 | mirvetuximab soravtansine-gynx 100 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2621553 | mirvetuximab soravtansine-gynx 100 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621553 | mirvetuximab soravtansine-gynx 100 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621554 | mirvetuximab soravtansine-gynx 5 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2621555 | Elahere | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2621556 | mirvetuximab soravtansine-gynx 5 MG/ML [Elahere] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2621557 | Elahere Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2621558 | mirvetuximab soravtansine Injection [Elahere] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2621559 | ELAHERE 100 MG in 20 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2621559 | ELAHERE 100 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2621559 | ELAHERE 100 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621559 | ELAHERE 100 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621560 | mirvetuximab soravtansine-gynx 5 MG/ML Injection [Elahere] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2621560 | mirvetuximab soravtansine-gynx 5 MG/ML Injection [Elahere] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2621571 | insulin lispro 100 UNT/ML in 3 ML Pen Injector with Sensor | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2621571 | insulin lispro 100 UNT/ML in 3 ML Pen Injector with Sensor | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621571 | insulin lispro 100 UNT/ML in 3 ML Pen Injector with Sensor | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621571 | insulin lispro 100 UNT/ML in 3 ML Pen Injector with Sensor | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2621572 | HumaLOG Tempo 100 UNT/ML in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621572 | HumaLOG Tempo 100 UNT/ML in 3 ML Pen Injector | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2621572 | HumaLOG Tempo 100 UNT/ML in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621572 | HumaLOG Tempo 100 UNT/ML in 3 ML Pen Injector | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2621572 | HumaLOG Tempo 100 UNT/ML in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2621572 | HumaLOG Tempo 100 UNT/ML in 3 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2621572 | HumaLOG Tempo 100 UNT/ML in 3 ML Pen Injector | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2621574 | alpha-lactalbumin (bovine) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2621575 | lidocaine / phenylephrine Rectal Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2621576 | lidocaine 5 % / phenylephrine HCl 0.25 % Rectal Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2621576 | lidocaine 5 % / phenylephrine HCl 0.25 % Rectal Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2621576 | lidocaine 5 % / phenylephrine HCl 0.25 % Rectal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2621641 | Aesculus chinensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2621642 | Anigozanthos flavidus flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2621643 | caprooyl phytosphingosine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2621644 | Davidsonia pruriens fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2621645 | pectin 3.8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2621646 | pectin 3.8 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2621646 | pectin 3.8 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2621647 | Bambara groundnut extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2621702 | Meloxivet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2621703 | meloxicam 5 MG/ML [Meloxivet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2621704 | Meloxivet Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2621705 | meloxicam Injectable Solution [Meloxivet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2621706 | Meloxivet 5 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2621706 | Meloxivet 5 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2621706 | Meloxivet 5 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2621708 | PEG-10 dimethicone (220 CST) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2621709 | Respirmycin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2621710 | tulathromycin 100 MG/ML [Respirmycin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2621711 | Respirmycin Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2621712 | tulathromycin Injectable Solution [Respirmycin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2621713 | RESPIRmycin 100 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2621713 | RESPIRmycin 100 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2621713 | RESPIRmycin 100 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2621715 | menthol 10 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2621715 | menthol 10 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2621715 | menthol 10 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2621716 | clindamycin Topical Foam [Clindacin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2621717 | Clindacin 1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621717 | Clindacin 1 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2621717 | Clindacin 1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621717 | Clindacin 1 % Topical Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2621718 | .delta.9-tetrahydrocannabinol acetate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2621718 | .delta.9-tetrahydrocannabinol acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2621720 | cinnamic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2621829 | Pulsatilla vulgaris top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2621830 | sodium oleyl sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2621831 | magnesium oleth sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2621832 | Magnolia sieboldii root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2621833 | Tulieve | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2621834 | tulathromycin 100 MG/ML [Tulieve] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2621835 | Tulieve Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2621836 | tulathromycin Injectable Solution [Tulieve] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2621837 | Tulieve 100 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2621837 | Tulieve 100 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2621837 | Tulieve 100 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2621880 | teplizumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2621881 | teplizumab-mzwv | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2621882 | teplizumab-mzwv 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2621883 | teplizumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2621884 | teplizumab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2621885 | teplizumab-mzwv 2 MG in 2 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2621885 | teplizumab-mzwv 2 MG in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2621885 | teplizumab-mzwv 2 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621886 | teplizumab-mzwv 1 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2621887 | Tzield | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2621888 | teplizumab-mzwv 1 MG/ML [Tzield] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2621889 | Tzield Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2621890 | teplizumab Injection [Tzield] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2621891 | Tzield 2 MG in 2 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2621891 | Tzield 2 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621891 | Tzield 2 MG in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2621891 | Tzield 2 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2621892 | teplizumab-mzwv 1 MG/ML Injection [Tzield] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2621892 | teplizumab-mzwv 1 MG/ML Injection [Tzield] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2621896 | histidinal, L- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2621898 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) 0.025 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2621899 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.025 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2621900 | SARS-CoV-2 vaccine, mRNA BNT162b2 bivalent original & OMICRON (BA.4/.5) Injectable Suspension, 5y through 11y (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2621900 | SARS-CoV-2 vaccine, mRNA BNT162b2 bivalent original & OMICRON (BA.4/.5) Injectable Suspension, 5y through 11y (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2621900 | SARS-CoV-2 vaccine, mRNA BNT162b2 bivalent original & OMICRON (BA.4/.5) Injectable Suspension, 5y through 11y (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 262191 | dexamethasone 1 MG/ML / neomycin 3.5 MG/ML Ophthalmic Solution [Neo-Dexair] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 262191 | dexamethasone 1 MG/ML / neomycin 3.5 MG/ML Ophthalmic Solution [Neo-Dexair] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 262191 | dexamethasone 1 MG/ML / neomycin 3.5 MG/ML Ophthalmic Solution [Neo-Dexair] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 262191 | dexamethasone 1 MG/ML / neomycin 3.5 MG/ML Ophthalmic Solution [Neo-Dexair] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 262197 | Multitrace-5 Concentrate (chromic chloride 51.3 MCG (chromium 10 MCG) / copper sulfate 3.93 MG (copper 1 MG) / manganese sulfate 1.54 MG (manganese 0.5 MG) / selenious acid 98 MCG (selenium 60 MCG) / zinc sulfate 22 MG (zinc 5 MG)) in 1 mL Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 262197 | Multitrace-5 Concentrate (chromic chloride 51.3 MCG (chromium 10 MCG) / copper sulfate 3.93 MG (copper 1 MG) / manganese sulfate 1.54 MG (manganese 0.5 MG) / selenious acid 98 MCG (selenium 60 MCG) / zinc sulfate 22 MG (zinc 5 MG)) in 1 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 262197 | Multitrace-5 Concentrate (chromic chloride 51.3 MCG (chromium 10 MCG) / copper sulfate 3.93 MG (copper 1 MG) / manganese sulfate 1.54 MG (manganese 0.5 MG) / selenious acid 98 MCG (selenium 60 MCG) / zinc sulfate 22 MG (zinc 5 MG)) in 1 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 262197 | Multitrace-5 Concentrate (chromic chloride 51.3 MCG (chromium 10 MCG) / copper sulfate 3.93 MG (copper 1 MG) / manganese sulfate 1.54 MG (manganese 0.5 MG) / selenious acid 98 MCG (selenium 60 MCG) / zinc sulfate 22 MG (zinc 5 MG)) in 1 mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 262197 | Multitrace-5 Concentrate (chromic chloride 51.3 MCG (chromium 10 MCG) / copper sulfate 3.93 MG (copper 1 MG) / manganese sulfate 1.54 MG (manganese 0.5 MG) / selenious acid 98 MCG (selenium 60 MCG) / zinc sulfate 22 MG (zinc 5 MG)) in 1 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2622 | clotiazepam | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2622 | clotiazepam | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2622 | clotiazepam | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 262219 | ACTIQ 400 MCG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 262219 | ACTIQ 400 MCG Oral Lozenge | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 262219 | ACTIQ 400 MCG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 262219 | ACTIQ 400 MCG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 262219 | ACTIQ 400 MCG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 262219 | ACTIQ 400 MCG Oral Lozenge | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 262221 | DYNACIN 75 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 262221 | DYNACIN 75 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 262221 | DYNACIN 75 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 262221 | DYNACIN 75 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 262222 | RisperDAL 0.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 262222 | RisperDAL 0.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 262222 | RisperDAL 0.5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 262222 | RisperDAL 0.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 262222 | RisperDAL 0.5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 262226 | ORAP 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 262226 | ORAP 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 262226 | ORAP 1 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2622304 | phellodendrine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2622305 | acetaminophen / guaifenesin Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2622305 | acetaminophen / guaifenesin Oral Powder Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2622306 | acetaminophen / guaifenesin Powder for Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2622306 | acetaminophen / guaifenesin Powder for Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2622307 | acetaminophen 1000 MG / guaiFENesin 400 MG Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2622307 | acetaminophen 1000 MG / guaiFENesin 400 MG Powder for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2622307 | acetaminophen 1000 MG / guaiFENesin 400 MG Powder for Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2622307 | acetaminophen 1000 MG / guaiFENesin 400 MG Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2622307 | acetaminophen 1000 MG / guaiFENesin 400 MG Powder for Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 262231 | hyoscyamine / methenamine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 262233 | Alocril | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 262237 | Feosol Caplet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 262241 | Simply Sleep | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 262242 | Teveten | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 26225 | Ondansetron | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 26225 | Ondansetron | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 26225 | Ondansetron | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 26225 | Ondansetron | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 26225 | Ondansetron | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 262263 | Scuttellaria lateriflora extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 262263 | Scuttellaria lateriflora extract | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 262263 | Scuttellaria lateriflora extract | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 262263 | Scuttellaria lateriflora extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 262272 | Product containing clotrimazole and hydrocortisone (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 262272 | Product containing clotrimazole and hydrocortisone (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 262272 | Product containing clotrimazole and hydrocortisone (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 262274 | La Crosse virus antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 262274 | La Crosse virus antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2622905 | Lippia sidoides leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2622906 | dimethicone PEG-8 meadowfoamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2622907 | polyacrylate-1 crosspolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2622910 | Vivimusta | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2622911 | bendamustine hydrochloride 25 MG/ML [Vivimusta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2622912 | Vivimusta Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2622913 | bendamustine Injectable Solution [Vivimusta] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2622914 | VIVIMUSTA 25 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2622914 | VIVIMUSTA 25 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2622914 | VIVIMUSTA 25 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2622915 | doxylamine succinate, (R)- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2622917 | Haloette | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2622918 | ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR [Haloette] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2622919 | Haloette Vaginal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2622920 | ethinyl estradiol / etonogestrel Vaginal System [Haloette] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2622921 | HALOETTE 0.12 MG / 0.015 MG per 24HR 3 Week Vaginal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2622921 | HALOETTE 0.12 MG / 0.015 MG per 24HR 3 Week Vaginal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2622921 | HALOETTE 0.12 MG / 0.015 MG per 24HR 3 Week Vaginal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2622922 | ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System [Haloette] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 262295 | succinylcholine iodide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 262296 | Trimebutine maleate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 262296 | Trimebutine maleate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 262296 | Trimebutine maleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 262299 | pefloxacin mesylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2623 | Clotrimazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2623 | Clotrimazole | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2623 | Clotrimazole | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2623 | Clotrimazole | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2623 | Clotrimazole | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 262302 | nomifensine maleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 262305 | Antibody variable region | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 262305 | Antibody variable region | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 262305 | Antibody variable region | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 262307 | Felbinac | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 262307 | Felbinac | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 262307 | Felbinac | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 262307 | Felbinac | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 262307 | Felbinac | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 262310 | Fenvalerate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 262310 | Fenvalerate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 262314 | Hypoglycin A | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 262314 | Hypoglycin A | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 262323 | ibritumomab tiuxetan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 262323 | ibritumomab tiuxetan | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 262323 | ibritumomab tiuxetan | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 262323 | ibritumomab tiuxetan | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 262323 | ibritumomab tiuxetan | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 262324 | Norflex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2623241 | camphor 0.0033 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2623242 | camphor 0.33 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2623242 | camphor 0.33 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2623242 | camphor 0.33 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2623243 | povidone 0.005 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2623244 | povidone Ophthalmic Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2623245 | povidone 0.5 % Ophthalmic Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2623245 | povidone 0.5 % Ophthalmic Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2623245 | povidone 0.5 % Ophthalmic Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2623246 | povidone 0.005 MG/MG [iVizia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2623247 | povidone Ophthalmic Gel [iVizia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2623248 | iVizia 0.5 % Ophthalmic Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2623248 | iVizia 0.5 % Ophthalmic Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2623248 | iVizia 0.5 % Ophthalmic Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2623248 | iVizia 0.5 % Ophthalmic Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2623376 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.025 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2623377 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5) 0.025 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2623378 | SARS-CoV-2 vaccine, mRNA-1273 bivalent original & OMICRON (BA.4/.5) Injectable Suspension, 6m through 5y (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2623378 | SARS-CoV-2 vaccine, mRNA-1273 bivalent original & OMICRON (BA.4/.5) Injectable Suspension, 6m through 5y (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2623378 | SARS-CoV-2 vaccine, mRNA-1273 bivalent original & OMICRON (BA.4/.5) Injectable Suspension, 6m through 5y (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2623380 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.0075 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2623381 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) 0.0075 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2623382 | SARS-CoV-2 vaccine, mRNA-BNT162b2 bivalent original & OMICRON (BA.4/.5) Injectable Suspension, 6m through 4y (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2623382 | SARS-CoV-2 vaccine, mRNA-BNT162b2 bivalent original & OMICRON (BA.4/.5) Injectable Suspension, 6m through 4y (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2623382 | SARS-CoV-2 vaccine, mRNA-BNT162b2 bivalent original & OMICRON (BA.4/.5) Injectable Suspension, 6m through 4y (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2623397 | Myrica cerifera fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 26234 | 3-(dimethylaminomethyl)indole | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 26234 | 3-(dimethylaminomethyl)indole | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 26234 | 3-(dimethylaminomethyl)indole | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 26234 | 3-(dimethylaminomethyl)indole | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2623403 | isocetyl isostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2623469 | isavuconazonium sulfate 74.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2623470 | isavuconazonium sulfate 74.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2623470 | isavuconazonium sulfate 74.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2623470 | isavuconazonium sulfate 74.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2623471 | isavuconazonium sulfate 74.5 MG [Cresemba] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2623472 | Cresemba 74.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2623472 | Cresemba 74.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2623472 | Cresemba 74.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2623472 | Cresemba 74.5 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2623473 | lidocaine 4 % / menthol 1 % / methyl salicylate 2 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2623473 | lidocaine 4 % / menthol 1 % / methyl salicylate 2 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2623473 | lidocaine 4 % / menthol 1 % / methyl salicylate 2 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2623641 | olutasidenib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2623642 | PEG-55 propylene glycol oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2623643 | Smallanthus sonchifolius root juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2623644 | olutasidenib 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2623645 | olutasidenib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2623646 | olutasidenib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2623647 | olutasidenib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2623648 | olutasidenib 150 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2623648 | olutasidenib 150 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2623649 | Rezlidhia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2623650 | olutasidenib 150 MG [Rezlidhia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2623651 | Rezlidhia Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2623652 | Rezlidhia Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2623653 | olutasidenib Oral Capsule [Rezlidhia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2623654 | REZLIDHIA 150 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2623654 | REZLIDHIA 150 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2623654 | REZLIDHIA 150 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2623655 | ePHEDrine sulfate 50 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2623655 | ePHEDrine sulfate 50 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2623655 | ePHEDrine sulfate 50 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2623656 | ephedrine Injectable Solution [Corphedra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2623656 | ephedrine Injectable Solution [Corphedra] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2623657 | Corphedra 50 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2623657 | Corphedra 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2623657 | Corphedra 50 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2623657 | Corphedra 50 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 26237 | Granisetron | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 26237 | Granisetron | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 26237 | Granisetron | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 26237 | Granisetron | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 26237 | Granisetron | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 262385 | Centrax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 262386 | Nobrium | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2623962 | zinc oxide 205 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2623963 | zinc oxide 20.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2623963 | zinc oxide 20.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2623963 | zinc oxide 20.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2623963 | zinc oxide 20.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2623973 | Flonase Nighttime | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2623974 | triprolidine hydrochloride 2.5 MG [Flonase Nighttime] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2623975 | Flonase Nighttime Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2623976 | Flonase Nighttime Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2623977 | triprolidine Oral Tablet [Flonase Nighttime] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2623978 | FLONASE Nighttime 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2623978 | FLONASE Nighttime 2.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2623978 | FLONASE Nighttime 2.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2623998 | Vitreoscilla lysate extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 262403 | Taractan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 26241 | Granulex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 262416 | Wy-4508 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 262418 | Altace | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2624201 | methyl salicylate 0.022 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2624202 | camphor 0.3 % / menthol 2.5 % / methyl salicylate 2.2 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2624202 | camphor 0.3 % / menthol 2.5 % / methyl salicylate 2.2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2624202 | camphor 0.3 % / menthol 2.5 % / methyl salicylate 2.2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2624203 | camphor 3 % / menthol 5 % / methyl salicylate 8 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2624203 | camphor 3 % / menthol 5 % / methyl salicylate 8 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2624203 | camphor 3 % / menthol 5 % / methyl salicylate 8 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2624207 | Rhuzdah 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2624207 | Rhuzdah 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2624207 | Rhuzdah 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 262444 | Tomudex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 262445 | R0 13-8996 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 262446 | ACN 6349 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 262449 | Zaditen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 262467 | LY 127935 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2624686 | lidocaine Rectal Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2624687 | lidocaine HCl 5 % Rectal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2624687 | lidocaine HCl 5 % Rectal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2624687 | lidocaine HCl 5 % Rectal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2624688 | cobaltous phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2624693 | cetyl diglyceryl tris(trimethylsiloxy)silylethyl dimethicone (3500 MM2/S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2624694 | ethoxydiglycol oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2624695 | saffron oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2624697 | dextroamphetamine 1.5 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2624698 | dextroamphetamine Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2624699 | dextroamphetamine Transdermal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 26247 | Cytotoxic T-lymphocyte proteinase 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 26247 | Cytotoxic T-lymphocyte proteinase 1 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 26247 | Cytotoxic T-lymphocyte proteinase 1 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2624700 | dextroamphetamine Transdermal System | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2624701 | dextroamphetamine 13.5 MG in 9 HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2624701 | dextroamphetamine 13.5 MG in 9 HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2624701 | dextroamphetamine 13.5 MG in 9 HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2624702 | dextroamphetamine 1.5 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2624703 | Xelstrym | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2624704 | dextroamphetamine 1.5 MG/HR [Xelstrym] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2624705 | Xelstrym Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2624706 | Xelstrym Transdermal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2624707 | dextroamphetamine Transdermal System [Xelstrym] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2624708 | Xelstrym 13.5 MG in 9 HR Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2624708 | Xelstrym 13.5 MG in 9 HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2624708 | Xelstrym 13.5 MG in 9 HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2624708 | Xelstrym 13.5 MG in 9 HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2624709 | dextroamphetamine 1.5 MG/HR Transdermal System [Xelstrym] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2624709 | dextroamphetamine 1.5 MG/HR Transdermal System [Xelstrym] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 262471 | Pondocillin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2624710 | camphor 5.5 % / menthol 16 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2624710 | camphor 5.5 % / menthol 16 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2624710 | camphor 5.5 % / menthol 16 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2624711 | dextroamphetamine 2 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2624712 | dextroamphetamine 18 MG in 9 HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2624712 | dextroamphetamine 18 MG in 9 HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2624712 | dextroamphetamine 18 MG in 9 HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2624713 | dextroamphetamine 2 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2624714 | dextroamphetamine 2 MG/HR [Xelstrym] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2624715 | Xelstrym 18 MG in 9 HR Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2624715 | Xelstrym 18 MG in 9 HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2624715 | Xelstrym 18 MG in 9 HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2624715 | Xelstrym 18 MG in 9 HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2624716 | dextroamphetamine 2 MG/HR Transdermal System [Xelstrym] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2624716 | dextroamphetamine 2 MG/HR Transdermal System [Xelstrym] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2624717 | phenobarbital sodium 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2624717 | phenobarbital sodium 100 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2624718 | phenobarbital Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2624718 | phenobarbital Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2624719 | PHENobarbital sodium 100 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2624719 | PHENobarbital sodium 100 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2624719 | PHENobarbital sodium 100 MG Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2624720 | Sezaby | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2624721 | phenobarbital sodium 100 MG [Sezaby] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2624721 | phenobarbital sodium 100 MG [Sezaby] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2624722 | Sezaby Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2624723 | phenobarbital Injection [Sezaby] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2624723 | phenobarbital Injection [Sezaby] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2624724 | Sezaby 100 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2624724 | Sezaby 100 MG Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2624724 | Sezaby 100 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2624724 | Sezaby 100 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2624725 | dextroamphetamine 0.5 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2624726 | dextroamphetamine 4.5 MG in 9 HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2624726 | dextroamphetamine 4.5 MG in 9 HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2624726 | dextroamphetamine 4.5 MG in 9 HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2624727 | dextroamphetamine 0.5 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2624728 | dextroamphetamine 0.5 MG/HR [Xelstrym] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2624729 | Xelstrym 4.5 MG in 9 HR Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2624729 | Xelstrym 4.5 MG in 9 HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2624729 | Xelstrym 4.5 MG in 9 HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2624729 | Xelstrym 4.5 MG in 9 HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2624730 | dextroamphetamine 0.5 MG/HR Transdermal System [Xelstrym] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2624730 | dextroamphetamine 0.5 MG/HR Transdermal System [Xelstrym] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2624731 | dextroamphetamine 1 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2624732 | dextroamphetamine 9 MG in 9 HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2624732 | dextroamphetamine 9 MG in 9 HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2624732 | dextroamphetamine 9 MG in 9 HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2624733 | dextroamphetamine 1 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2624734 | dextroamphetamine 1 MG/HR [Xelstrym] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2624735 | Xelstrym 9 MG in 9 HR Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2624735 | Xelstrym 9 MG in 9 HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2624735 | Xelstrym 9 MG in 9 HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2624735 | Xelstrym 9 MG in 9 HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2624736 | dextroamphetamine 1 MG/HR Transdermal System [Xelstrym] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2624736 | dextroamphetamine 1 MG/HR Transdermal System [Xelstrym] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2624741 | Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2624742 | Zaire ebolavirus envelope glycoprotein | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2624743 | Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein 72000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2624744 | Zaire ebolavirus envelope glycoprotein Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2624745 | Zaire ebolavirus envelope glycoprotein Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2624746 | Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein 72,000,000 UNT in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2624746 | Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein 72,000,000 UNT in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2624746 | Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein 72,000,000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2624747 | Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein 72000000 UNT/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2624748 | Ervebo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2624749 | Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein 72000000 UNT/ML [Ervebo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2624750 | Ervebo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2624751 | Zaire ebolavirus envelope glycoprotein Injection [Ervebo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2624752 | ERVEBO 72,000,000 UNT in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2624752 | ERVEBO 72,000,000 UNT in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2624752 | ERVEBO 72,000,000 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2624753 | Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein 72000000 UNT/ML Injection [Ervebo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2624753 | Zaire ebolavirus (strain Kikwit-95) envelope glycoprotein 72000000 UNT/ML Injection [Ervebo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 26248 | Cytotoxic T-lymphocyte proteinase 2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 26248 | Cytotoxic T-lymphocyte proteinase 2 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 26248 | Cytotoxic T-lymphocyte proteinase 2 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 262485 | Arimidex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2624887 | Brassica oleracea whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2624891 | clinoptilolite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2624893 | Canavalia ensiformis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2625 | Cloxacillin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2625 | Cloxacillin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2625 | Cloxacillin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2625 | Cloxacillin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2625 | Cloxacillin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 262500 | Prostigmin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 262501 | Trilisate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2625116 | glycerin 6.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2625117 | glycerin / povidone | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 2625118 | glycerin / povidone Ophthalmic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2625119 | glycerin / povidone Ophthalmic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2625120 | glycerin 0.63 % / povidone 0.25 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2625120 | glycerin 0.63 % / povidone 0.25 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2625120 | glycerin 0.63 % / povidone 0.25 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2625121 | p-methylaminophenol sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2625122 | mosunetuzumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2625123 | 2-nonylphenol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2625124 | apple peel extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2625125 | mosunetuzumab-axgb | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2625126 | mosunetuzumab-axgb 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2625127 | mosunetuzumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2625128 | mosunetuzumab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2625129 | mosunetuzumab-axgb 1 MG in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2625129 | mosunetuzumab-axgb 1 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2625129 | mosunetuzumab-axgb 1 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625129 | mosunetuzumab-axgb 1 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625130 | mosunetuzumab-axgb 1 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2625131 | Lunsumio | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2625132 | mosunetuzumab-axgb 1 MG/ML [Lunsumio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2625133 | Lunsumio Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2625134 | mosunetuzumab Injection [Lunsumio] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2625135 | Lunsumio 1 MG in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2625135 | Lunsumio 1 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2625135 | Lunsumio 1 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625135 | Lunsumio 1 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625136 | mosunetuzumab-axgb 1 MG/ML Injection [Lunsumio] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2625136 | mosunetuzumab-axgb 1 MG/ML Injection [Lunsumio] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2625137 | mosunetuzumab-axgb 30 MG in 30 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2625137 | mosunetuzumab-axgb 30 MG in 30 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625137 | mosunetuzumab-axgb 30 MG in 30 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2625137 | mosunetuzumab-axgb 30 MG in 30 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625138 | Lunsumio 30 MG in 30 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2625138 | Lunsumio 30 MG in 30 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625138 | Lunsumio 30 MG in 30 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2625138 | Lunsumio 30 MG in 30 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625139 | allantoin 3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2625140 | allantoin 0.3 % / benzalkonium chloride 0.2 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2625140 | allantoin 0.3 % / benzalkonium chloride 0.2 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2625140 | allantoin 0.3 % / benzalkonium chloride 0.2 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2625141 | omeprazole 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2625142 | omeprazole / sodium bicarbonate Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2625143 | omeprazole / sodium bicarbonate Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2625144 | omeprazole 2 MG/mL / sodium bicarbonate 84 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625144 | omeprazole 2 MG/mL / sodium bicarbonate 84 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2625144 | omeprazole 2 MG/mL / sodium bicarbonate 84 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2625145 | Konvomep | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2625146 | omeprazole 2 MG/ML / sodium bicarbonate 84 MG/ML [Konvomep] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2625147 | Konvomep Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2625148 | Konvomep Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2625149 | omeprazole / sodium bicarbonate Oral Suspension [Konvomep] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2625150 | KONVOMEP 2 MG / 84 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625150 | KONVOMEP 2 MG / 84 MG in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2625150 | KONVOMEP 2 MG / 84 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625150 | KONVOMEP 2 MG / 84 MG in 1 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2625171 | carboxymethylcellulose sodium 12 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 262564 | Benlate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2625644 | 2,3,5,6-tetrafluorophenol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2625645 | octyldodecyl erucate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2625647 | docusate sodium 20 MG/ML [Enemeez] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2625648 | Enemeez Kids 100 MG per 5 mL Enema | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2625648 | Enemeez Kids 100 MG per 5 mL Enema | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625648 | Enemeez Kids 100 MG per 5 mL Enema | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625648 | Enemeez Kids 100 MG per 5 mL Enema | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2625648 | Enemeez Kids 100 MG per 5 mL Enema | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625651 | lenacapavir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2625652 | lenacapavir sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 26257 | Andromedotoxin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 26257 | Andromedotoxin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 26257 | Andromedotoxin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 26257 | Andromedotoxin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 26257 | Andromedotoxin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2625882 | adagrasib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2625886 | lenacapavir 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2625887 | lenacapavir Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2625888 | lenacapavir Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2625889 | lenacapavir Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2625890 | lenacapavir 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625890 | lenacapavir 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2625890 | lenacapavir 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2625891 | Sunlenca | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2625892 | lenacapavir 300 MG [Sunlenca] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2625893 | Sunlenca Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2625894 | Sunlenca Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2625895 | lenacapavir Oral Tablet [Sunlenca] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2625896 | Sunlenca 300 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2625896 | Sunlenca 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2625896 | Sunlenca 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625897 | lenacapavir 300 MG 4-Tablet Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2625897 | lenacapavir 300 MG 4-Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2625897 | lenacapavir 300 MG 4-Tablet Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625898 | Sunlenca 4-Tablet Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2625898 | Sunlenca 4-Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2625898 | Sunlenca 4-Tablet Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625899 | lenacapavir 300 MG 5-Tablet Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2625899 | lenacapavir 300 MG 5-Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2625899 | lenacapavir 300 MG 5-Tablet Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625900 | Sunlenca 5-Tablet Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2625900 | Sunlenca 5-Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2625900 | Sunlenca 5-Tablet Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625901 | lenacapavir 309 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2625902 | lenacapavir Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2625903 | lenacapavir Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2625904 | lenacapavir 463.5 MG in 1.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2625904 | lenacapavir 463.5 MG in 1.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2625904 | lenacapavir 463.5 MG in 1.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625905 | lenacapavir 309 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2625906 | lenacapavir 309 MG/ML [Sunlenca] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2625907 | Sunlenca Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2625908 | lenacapavir Injection [Sunlenca] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2625909 | Sunlenca 463.5 MG in 1.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2625909 | Sunlenca 463.5 MG in 1.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625909 | Sunlenca 463.5 MG in 1.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2625909 | Sunlenca 463.5 MG in 1.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625910 | lenacapavir 309 MG/ML Injection [Sunlenca] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2625910 | lenacapavir 309 MG/ML Injection [Sunlenca] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2625911 | lenacapavir 927 MG 2-Vial Kit | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2625911 | lenacapavir 927 MG 2-Vial Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2625911 | lenacapavir 927 MG 2-Vial Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625912 | Sunlenca 927 MG 2-Vial Kit | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2625912 | Sunlenca 927 MG 2-Vial Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2625912 | Sunlenca 927 MG 2-Vial Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2625913 | adagrasib 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2625914 | adagrasib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2625915 | adagrasib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2625916 | adagrasib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2625917 | adagrasib 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2625917 | adagrasib 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2625918 | Krazati | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2625919 | adagrasib 200 MG [Krazati] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2625920 | Krazati Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2625921 | Krazati Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2625922 | adagrasib Oral Tablet [Krazati] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2625923 | KRAZATI 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2625923 | KRAZATI 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2625923 | KRAZATI 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 262594 | Zoalene | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 262594 | Zoalene | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2626 | Clozapine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2626 | Clozapine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2626 | Clozapine | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2626 | Clozapine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2626 | Clozapine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2626 | Clozapine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2626049 | levothyroxine sodium 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2626050 | levothyroxine sodium 150 MCG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2626050 | levothyroxine sodium 150 MCG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626050 | levothyroxine sodium 150 MCG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626050 | levothyroxine sodium 150 MCG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626051 | Ermeza | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2626052 | levothyroxine sodium 0.03 MG/ML [Ermeza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2626053 | Ermeza Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2626054 | Ermeza Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2626055 | levothyroxine Oral Solution [Ermeza] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626056 | Ermeza 150 MCG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626056 | Ermeza 150 MCG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626056 | Ermeza 150 MCG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626056 | Ermeza 150 MCG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626056 | Ermeza 150 MCG in 5 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 262606 | Panacur | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2626142 | lecanemab-irmb | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2626143 | lecanemab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2626144 | lecanemab-irmb 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2626145 | lecanemab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2626146 | lecanemab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2626147 | lecanemab-irmb 200 MG in 2 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2626147 | lecanemab-irmb 200 MG in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626147 | lecanemab-irmb 200 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626148 | lecanemab-irmb 100 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2626148 | lecanemab-irmb 100 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2626148 | lecanemab-irmb 100 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626149 | Leqembi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2626150 | lecanemab-irmb 100 MG/ML [Leqembi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2626151 | Leqembi Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2626152 | lecanemab Injection [Leqembi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626153 | LEQEMBI 200 MG in 2 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626153 | LEQEMBI 200 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626153 | LEQEMBI 200 MG in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626153 | LEQEMBI 200 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626154 | LEQEMBI 100 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2626154 | LEQEMBI 100 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2626154 | LEQEMBI 100 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626155 | lecanemab-irmb 500 MG in 5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2626155 | lecanemab-irmb 500 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626155 | lecanemab-irmb 500 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626156 | LEQEMBI 500 MG in 5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626156 | LEQEMBI 500 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626156 | LEQEMBI 500 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626156 | LEQEMBI 500 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626219 | xenon-129 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2626220 | xenon-129, hyperpolarized | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2626341 | sodium chloride 2.1 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626341 | sodium chloride 2.1 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2626341 | sodium chloride 2.1 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626341 | sodium chloride 2.1 % Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2626342 | sodium chloride 21 MG/ML [Aqua Maris] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2626343 | Aqua Maris 2.1 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2626343 | Aqua Maris 2.1 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626343 | Aqua Maris 2.1 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626343 | Aqua Maris 2.1 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626343 | Aqua Maris 2.1 % Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2626344 | sodium chloride 36 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2626345 | sodium chloride 3.6 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626345 | sodium chloride 3.6 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2626345 | sodium chloride 3.6 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626345 | sodium chloride 3.6 % Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2626346 | sodium chloride 36 MG/ML [Aqua Maris] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2626347 | Aqua Maris 3.6 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2626347 | Aqua Maris 3.6 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626347 | Aqua Maris 3.6 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626347 | Aqua Maris 3.6 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626347 | Aqua Maris 3.6 % Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2626348 | ublituximab-xiiy | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2626349 | ublituximab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 262635 | Prioderm | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2626350 | ublituximab-xiiy 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2626351 | ublituximab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2626352 | ublituximab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2626353 | ublituximab-xiiy 150 MG in 6 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2626353 | ublituximab-xiiy 150 MG in 6 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626353 | ublituximab-xiiy 150 MG in 6 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626354 | ublituximab-xiiy 25 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2626354 | ublituximab-xiiy 25 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2626354 | ublituximab-xiiy 25 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626355 | Briumvi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2626356 | ublituximab-xiiy 25 MG/ML [Briumvi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2626357 | Briumvi Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2626358 | ublituximab Injection [Briumvi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626359 | Briumvi 150 MG in 6 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626359 | Briumvi 150 MG in 6 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626359 | Briumvi 150 MG in 6 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626359 | Briumvi 150 MG in 6 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626360 | Briumvi 25 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2626360 | Briumvi 25 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626360 | Briumvi 25 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2626361 | citric acid 68.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2626362 | magnesium oxide 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2626363 | picosulfate sodium 0.0571 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2626364 | citric acid 12 GM / magnesium oxide 3.5 GM / picosulfate sodium 10 MG in 175 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626364 | citric acid 12 GM / magnesium oxide 3.5 GM / picosulfate sodium 10 MG in 175 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626364 | citric acid 12 GM / magnesium oxide 3.5 GM / picosulfate sodium 10 MG in 175 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2626365 | citric acid 68.6 MG/ML / magnesium oxide 20 MG/ML / picosulfate sodium 0.0571 MG/ML [Clenpiq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2626366 | CLENPIQ 10 MG / 3.5 GM / 12 GM in 175 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626366 | CLENPIQ 10 MG / 3.5 GM / 12 GM in 175 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626366 | CLENPIQ 10 MG / 3.5 GM / 12 GM in 175 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626367 | sodium phenylbutyrate 2000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2626368 | phenylbutyrate Granules for Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2626369 | sodium phenylbutyrate 2 GM Granules for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626369 | sodium phenylbutyrate 2 GM Granules for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626369 | sodium phenylbutyrate 2 GM Granules for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2626370 | Olpruva | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2626371 | sodium phenylbutyrate 2000 MG [Olpruva] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2626372 | Olpruva Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2626373 | Olpruva Granule Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2626374 | phenylbutyrate Granules for Oral Suspension [Olpruva] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626375 | OLPRUVA 2 GM Granules for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626375 | OLPRUVA 2 GM Granules for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626375 | OLPRUVA 2 GM Granules for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626376 | sodium phenylbutyrate 3 GM Granules for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626376 | sodium phenylbutyrate 3 GM Granules for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626376 | sodium phenylbutyrate 3 GM Granules for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2626377 | sodium phenylbutyrate 3000 MG [Olpruva] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2626378 | OLPRUVA 3 GM Granules for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626378 | OLPRUVA 3 GM Granules for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626378 | OLPRUVA 3 GM Granules for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626379 | sodium phenylbutyrate 3670 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2626380 | sodium phenylbutyrate 3.67 GM Granules for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626380 | sodium phenylbutyrate 3.67 GM Granules for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626380 | sodium phenylbutyrate 3.67 GM Granules for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2626381 | sodium phenylbutyrate 3670 MG [Olpruva] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2626382 | OLPRUVA 3.67 GM Granules for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626382 | OLPRUVA 3.67 GM Granules for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626382 | OLPRUVA 3.67 GM Granules for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626383 | fingolimod 0.5 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626383 | fingolimod 0.5 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2626384 | fingolimod 0.5 MG [Tascenso] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2626385 | Tascenso ODT 0.5 MG Disintegrating Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626385 | Tascenso ODT 0.5 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626385 | Tascenso ODT 0.5 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626386 | sodium phenylbutyrate 2 GM Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626386 | sodium phenylbutyrate 2 GM Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626386 | sodium phenylbutyrate 2 GM Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626387 | OLPRUVA 2 GM Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626387 | OLPRUVA 2 GM Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626387 | OLPRUVA 2 GM Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626388 | sodium phenylbutyrate 3 GM Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626388 | sodium phenylbutyrate 3 GM Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626388 | sodium phenylbutyrate 3 GM Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626389 | OLPRUVA 3 GM Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626389 | OLPRUVA 3 GM Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626389 | OLPRUVA 3 GM Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626390 | sodium phenylbutyrate 4 GM Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626390 | sodium phenylbutyrate 4 GM Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626390 | sodium phenylbutyrate 4 GM Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626391 | OLPRUVA 4 GM Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626391 | OLPRUVA 4 GM Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626391 | OLPRUVA 4 GM Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626392 | sodium phenylbutyrate 5 GM Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626392 | sodium phenylbutyrate 5 GM Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626392 | sodium phenylbutyrate 5 GM Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626393 | OLPRUVA 5 GM Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626393 | OLPRUVA 5 GM Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626393 | OLPRUVA 5 GM Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626394 | sodium phenylbutyrate 6 GM Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626394 | sodium phenylbutyrate 6 GM Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626394 | sodium phenylbutyrate 6 GM Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626395 | OLPRUVA 6 GM Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626395 | OLPRUVA 6 GM Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626395 | OLPRUVA 6 GM Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626396 | pexidartinib 125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2626397 | pexidartinib 125 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626397 | pexidartinib 125 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2626398 | pexidartinib 125 MG [Turalio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2626399 | Turalio 125 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626399 | Turalio 125 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626399 | Turalio 125 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626400 | sodium phenylbutyrate 6.67 GM Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626400 | sodium phenylbutyrate 6.67 GM Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626400 | sodium phenylbutyrate 6.67 GM Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626401 | OLPRUVA 6.67 GM Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626401 | OLPRUVA 6.67 GM Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626401 | OLPRUVA 6.67 GM Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626459 | allogeneic processed thymus tissue-agdc | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2626460 | allogeneic processed thymus tissue | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2626461 | allogeneic processed thymus tissue-agdc 220 SQCM | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2626462 | allogeneic processed thymus tissue Drug Implant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2626463 | allogeneic processed thymus tissue Drug Implant | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2626464 | allogeneic processed thymus tissue-agdc Drug Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626464 | allogeneic processed thymus tissue-agdc Drug Implant | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2626464 | allogeneic processed thymus tissue-agdc Drug Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626465 | Rethymic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2626466 | allogeneic processed thymus tissue-agdc 220 SQCM [Rethymic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2626467 | Rethymic Drug Implant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2626468 | allogeneic processed thymus tissue Drug Implant [Rethymic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626469 | RETHYMIC Drug Implant | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626469 | RETHYMIC Drug Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626469 | RETHYMIC Drug Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626469 | RETHYMIC Drug Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626469 | RETHYMIC Drug Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626470 | allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2626471 | allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2626472 | allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat 100 SQCM | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2626473 | allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2626474 | allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen Medicated Patch | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2626475 | allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat 100 SQCM Topical Cellular Sheet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2626475 | allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat 100 SQCM Topical Cellular Sheet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626475 | allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat 100 SQCM Topical Cellular Sheet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626476 | Stratagraft | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2626477 | allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat 100 SQCM [Stratagraft] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2626478 | Stratagraft Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2626479 | allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen Medicated Patch [Stratagraft] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626480 | STRATAGRAFT 100 SQCM Topical Cellular Sheet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626480 | STRATAGRAFT 100 SQCM Topical Cellular Sheet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626480 | STRATAGRAFT 100 SQCM Topical Cellular Sheet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626480 | STRATAGRAFT 100 SQCM Topical Cellular Sheet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626481 | Euthaphen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2626482 | pentobarbital sodium 390 MG/ML / phenytoin sodium 50 MG/ML [Euthaphen] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2626482 | pentobarbital sodium 390 MG/ML / phenytoin sodium 50 MG/ML [Euthaphen] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2626483 | Euthaphen Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2626484 | pentobarbital / phenytoin Injectable Solution [Euthaphen] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2626484 | pentobarbital / phenytoin Injectable Solution [Euthaphen] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2626485 | Euthaphen 390 MG / 50 MG in 1 ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626485 | Euthaphen 390 MG / 50 MG in 1 ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2626485 | Euthaphen 390 MG / 50 MG in 1 ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2626485 | Euthaphen 390 MG / 50 MG in 1 ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626485 | Euthaphen 390 MG / 50 MG in 1 ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2626485 | Euthaphen 390 MG / 50 MG in 1 ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2626485 | Euthaphen 390 MG / 50 MG in 1 ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2626488 | Pentobarsol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2626490 | Pentobarsol Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2626491 | pentobarbital Injectable Solution [Pentobarsol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2626491 | pentobarbital Injectable Solution [Pentobarsol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2626493 | pentobarbital sodium 390 MG/ML [Pentobarsol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2626493 | pentobarbital sodium 390 MG/ML [Pentobarsol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2626494 | Pentobarsol 390 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2626494 | Pentobarsol 390 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2626494 | Pentobarsol 390 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2626494 | Pentobarsol 390 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626495 | Smilax glabra whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2626496 | dextromethorphan hydrobromide 0.667 MG/ML / guaiFENesin 13.33 MG/ML / phenylephrine hydrochloride 0.333 MG/ML Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2626496 | dextromethorphan hydrobromide 0.667 MG/ML / guaiFENesin 13.33 MG/ML / phenylephrine hydrochloride 0.333 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2626496 | dextromethorphan hydrobromide 0.667 MG/ML / guaiFENesin 13.33 MG/ML / phenylephrine hydrochloride 0.333 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2626497 | 1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG per 15 mL) / 1 nighttime (diphenhydrAMINE HCl 12.5 MG / phenylephrine HCl 5 MG per 15 mL) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| Concept ID (RxCUI): 2626497 | 1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG per 15 mL) / 1 nighttime (diphenhydrAMINE HCl 12.5 MG / phenylephrine HCl 5 MG per 15 mL) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2626497 | 1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG per 15 mL) / 1 nighttime (diphenhydrAMINE HCl 12.5 MG / phenylephrine HCl 5 MG per 15 mL) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2626497 | 1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG per 15 mL) / 1 nighttime (diphenhydrAMINE HCl 12.5 MG / phenylephrine HCl 5 MG per 15 mL) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626497 | 1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG per 15 mL) / 1 nighttime (diphenhydrAMINE HCl 12.5 MG / phenylephrine HCl 5 MG per 15 mL) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2626641 | Pentosol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2626642 | pentobarbital sodium 390 MG/ML [Pentosol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2626642 | pentobarbital sodium 390 MG/ML [Pentosol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2626643 | Pentosol Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2626644 | pentobarbital Injectable Solution [Pentosol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2626644 | pentobarbital Injectable Solution [Pentosol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2626645 | Pentosol 390 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2626645 | Pentosol 390 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2626645 | Pentosol 390 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2626645 | Pentosol 390 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626722 | anacaulase-bcdb | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2626723 | anacaulase | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2626724 | donor human stool | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626724 | donor human stool | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2626726 | aspirin 650 MG / caffeine 65 MG Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626726 | aspirin 650 MG / caffeine 65 MG Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2626726 | aspirin 650 MG / caffeine 65 MG Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2626727 | etranacogene dezaparvovec | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2626728 | fecal microbiota, live-jslm | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2626729 | fecal microbiota, live-jslm 50000000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2626730 | fecal microbiota, live Rectal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2626731 | fecal microbiota, live Enema | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2626732 | fecal microbiota, live-jslm 150 ML Enema | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626732 | fecal microbiota, live-jslm 150 ML Enema | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626732 | fecal microbiota, live-jslm 150 ML Enema | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2626733 | Rebyota | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2626734 | fecal microbiota, live-jslm 50000000000 UNT/ML [Rebyota] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2626735 | Rebyota Rectal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2626736 | fecal microbiota, live Enema [Rebyota] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626737 | REBYOTA 150 ML Enema | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626737 | REBYOTA 150 ML Enema | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626737 | REBYOTA 150 ML Enema | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626739 | anacaulase Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2626740 | anacaulase Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2626743 | Nexobrid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2626745 | Nexobrid Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2626746 | anacaulase Topical Gel [Nexobrid] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626750 | anacaulase-bcdb 0.088 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2626751 | anacaulase-bcdb 8.8 % Topical Gel, 22 GM | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2626751 | anacaulase-bcdb 8.8 % Topical Gel, 22 GM | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626751 | anacaulase-bcdb 8.8 % Topical Gel, 22 GM | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626752 | anacaulase-bcdb 0.088 MG/MG Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2626753 | anacaulase-bcdb 0.088 MG/MG [Nexobrid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2626754 | NexoBrid 8.8 % Topical Gel, 22 GM | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626754 | NexoBrid 8.8 % Topical Gel, 22 GM | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626754 | NexoBrid 8.8 % Topical Gel, 22 GM | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626754 | NexoBrid 8.8 % Topical Gel, 22 GM | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626755 | anacaulase-bcdb 0.088 MG/MG Topical Gel [Nexobrid] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2626755 | anacaulase-bcdb 0.088 MG/MG Topical Gel [Nexobrid] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626757 | anacaulase-bcdb 8.8 % Topical Gel, 55 GM | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2626757 | anacaulase-bcdb 8.8 % Topical Gel, 55 GM | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626757 | anacaulase-bcdb 8.8 % Topical Gel, 55 GM | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626758 | NexoBrid 8.8 % Topical Gel, 55 GM | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626758 | NexoBrid 8.8 % Topical Gel, 55 GM | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626758 | NexoBrid 8.8 % Topical Gel, 55 GM | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626758 | NexoBrid 8.8 % Topical Gel, 55 GM | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626768 | etranacogene dezaparvovec-drlb | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2626769 | etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2626770 | etranacogene dezaparvovec Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2626771 | etranacogene dezaparvovec Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2626772 | etranacogene dezaparvovec-drlb 100000000000000 VECTOR-GENOMES in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2626772 | etranacogene dezaparvovec-drlb 100000000000000 VECTOR-GENOMES in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626772 | etranacogene dezaparvovec-drlb 100000000000000 VECTOR-GENOMES in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626772 | etranacogene dezaparvovec-drlb 100000000000000 VECTOR-GENOMES in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626773 | etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2626773 | etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2626774 | Hemgenix | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2626775 | etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML [Hemgenix] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2626776 | Hemgenix Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2626777 | etranacogene dezaparvovec Injection [Hemgenix] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626778 | HEMGENIX 100000000000000 VECTOR-GENOMES in 10 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2626778 | HEMGENIX 100000000000000 VECTOR-GENOMES in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626778 | HEMGENIX 100000000000000 VECTOR-GENOMES in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626778 | HEMGENIX 100000000000000 VECTOR-GENOMES in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626779 | etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2626779 | etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection [Hemgenix] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626780 | etranacogene dezaparvovec-drlb Kit Patient Weight 46 - 50 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626780 | etranacogene dezaparvovec-drlb Kit Patient Weight 46 - 50 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626780 | etranacogene dezaparvovec-drlb Kit Patient Weight 46 - 50 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626781 | HEMGENIX Kit Patient Weight 46 - 50 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626781 | HEMGENIX Kit Patient Weight 46 - 50 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626781 | HEMGENIX Kit Patient Weight 46 - 50 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626782 | etranacogene dezaparvovec-drlb Kit Patient Weight 51 - 55 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626782 | etranacogene dezaparvovec-drlb Kit Patient Weight 51 - 55 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626782 | etranacogene dezaparvovec-drlb Kit Patient Weight 51 - 55 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626783 | HEMGENIX Kit Patient Weight 51 - 55 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626783 | HEMGENIX Kit Patient Weight 51 - 55 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626783 | HEMGENIX Kit Patient Weight 51 - 55 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626784 | etranacogene dezaparvovec-drlb Kit Patient Weight 56 - 60 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626784 | etranacogene dezaparvovec-drlb Kit Patient Weight 56 - 60 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626784 | etranacogene dezaparvovec-drlb Kit Patient Weight 56 - 60 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626785 | HEMGENIX Kit Patient Weight 56 - 60 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626785 | HEMGENIX Kit Patient Weight 56 - 60 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626785 | HEMGENIX Kit Patient Weight 56 - 60 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626786 | etranacogene dezaparvovec-drlb Kit Patient Weight 61 - 65 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626786 | etranacogene dezaparvovec-drlb Kit Patient Weight 61 - 65 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626786 | etranacogene dezaparvovec-drlb Kit Patient Weight 61 - 65 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626787 | HEMGENIX Kit Patient Weight 61 - 65 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626787 | HEMGENIX Kit Patient Weight 61 - 65 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626787 | HEMGENIX Kit Patient Weight 61 - 65 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626788 | etranacogene dezaparvovec-drlb Kit Patient Weight 66 - 70 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626788 | etranacogene dezaparvovec-drlb Kit Patient Weight 66 - 70 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626788 | etranacogene dezaparvovec-drlb Kit Patient Weight 66 - 70 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626789 | HEMGENIX Kit Patient Weight 66 - 70 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626789 | HEMGENIX Kit Patient Weight 66 - 70 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626789 | HEMGENIX Kit Patient Weight 66 - 70 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626790 | etranacogene dezaparvovec-drlb Kit Patient Weight 71 - 75 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626790 | etranacogene dezaparvovec-drlb Kit Patient Weight 71 - 75 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626790 | etranacogene dezaparvovec-drlb Kit Patient Weight 71 - 75 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626791 | HEMGENIX Kit Patient Weight 71 - 75 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626791 | HEMGENIX Kit Patient Weight 71 - 75 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626791 | HEMGENIX Kit Patient Weight 71 - 75 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626792 | etranacogene dezaparvovec-drlb Kit Patient Weight 76 - 80 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626792 | etranacogene dezaparvovec-drlb Kit Patient Weight 76 - 80 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626792 | etranacogene dezaparvovec-drlb Kit Patient Weight 76 - 80 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626793 | HEMGENIX Kit Patient Weight 76 - 80 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626793 | HEMGENIX Kit Patient Weight 76 - 80 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626793 | HEMGENIX Kit Patient Weight 76 - 80 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626794 | etranacogene dezaparvovec-drlb Kit Patient Weight 81 - 85 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626794 | etranacogene dezaparvovec-drlb Kit Patient Weight 81 - 85 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626794 | etranacogene dezaparvovec-drlb Kit Patient Weight 81 - 85 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626795 | HEMGENIX Kit Patient Weight 81 - 85 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626795 | HEMGENIX Kit Patient Weight 81 - 85 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626795 | HEMGENIX Kit Patient Weight 81 - 85 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626796 | etranacogene dezaparvovec-drlb Kit Patient Weight 86 - 90 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626796 | etranacogene dezaparvovec-drlb Kit Patient Weight 86 - 90 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626796 | etranacogene dezaparvovec-drlb Kit Patient Weight 86 - 90 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626797 | HEMGENIX Kit Patient Weight 86 - 90 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626797 | HEMGENIX Kit Patient Weight 86 - 90 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626797 | HEMGENIX Kit Patient Weight 86 - 90 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626798 | etranacogene dezaparvovec-drlb Kit Patient Weight 91 - 95 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626798 | etranacogene dezaparvovec-drlb Kit Patient Weight 91 - 95 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626798 | etranacogene dezaparvovec-drlb Kit Patient Weight 91 - 95 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626799 | HEMGENIX Kit Patient Weight 91 - 95 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626799 | HEMGENIX Kit Patient Weight 91 - 95 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626799 | HEMGENIX Kit Patient Weight 91 - 95 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626800 | etranacogene dezaparvovec-drlb Kit Patient Weight 96 - 100 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626800 | etranacogene dezaparvovec-drlb Kit Patient Weight 96 - 100 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626800 | etranacogene dezaparvovec-drlb Kit Patient Weight 96 - 100 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626801 | HEMGENIX Kit Patient Weight 96 - 100 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626801 | HEMGENIX Kit Patient Weight 96 - 100 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626801 | HEMGENIX Kit Patient Weight 96 - 100 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626802 | etranacogene dezaparvovec-drlb Kit Patient Weight 101 - 105 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626802 | etranacogene dezaparvovec-drlb Kit Patient Weight 101 - 105 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626802 | etranacogene dezaparvovec-drlb Kit Patient Weight 101 - 105 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626803 | HEMGENIX Kit Patient Weight 101 - 105 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626803 | HEMGENIX Kit Patient Weight 101 - 105 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626803 | HEMGENIX Kit Patient Weight 101 - 105 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626804 | etranacogene dezaparvovec-drlb Kit Patient Weight 106 - 110 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626804 | etranacogene dezaparvovec-drlb Kit Patient Weight 106 - 110 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626804 | etranacogene dezaparvovec-drlb Kit Patient Weight 106 - 110 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626805 | HEMGENIX Kit Patient Weight 106 - 110 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626805 | HEMGENIX Kit Patient Weight 106 - 110 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626805 | HEMGENIX Kit Patient Weight 106 - 110 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626806 | etranacogene dezaparvovec-drlb Kit Patient Weight 111 - 115 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626806 | etranacogene dezaparvovec-drlb Kit Patient Weight 111 - 115 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626806 | etranacogene dezaparvovec-drlb Kit Patient Weight 111 - 115 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626807 | HEMGENIX Kit Patient Weight 111 - 115 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626807 | HEMGENIX Kit Patient Weight 111 - 115 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626807 | HEMGENIX Kit Patient Weight 111 - 115 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626808 | etranacogene dezaparvovec-drlb Kit Patient Weight 116 - 120 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626808 | etranacogene dezaparvovec-drlb Kit Patient Weight 116 - 120 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626808 | etranacogene dezaparvovec-drlb Kit Patient Weight 116 - 120 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626809 | HEMGENIX Kit Patient Weight 116 - 120 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626809 | HEMGENIX Kit Patient Weight 116 - 120 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626809 | HEMGENIX Kit Patient Weight 116 - 120 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626810 | etranacogene dezaparvovec-drlb Kit Patient Weight 121 - 125 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626810 | etranacogene dezaparvovec-drlb Kit Patient Weight 121 - 125 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626810 | etranacogene dezaparvovec-drlb Kit Patient Weight 121 - 125 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626811 | HEMGENIX Kit Patient Weight 121 - 125 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626811 | HEMGENIX Kit Patient Weight 121 - 125 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626811 | HEMGENIX Kit Patient Weight 121 - 125 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626812 | etranacogene dezaparvovec-drlb Kit Patient Weight 126 - 130 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626812 | etranacogene dezaparvovec-drlb Kit Patient Weight 126 - 130 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626812 | etranacogene dezaparvovec-drlb Kit Patient Weight 126 - 130 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626813 | HEMGENIX Kit Patient Weight 126 - 130 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626813 | HEMGENIX Kit Patient Weight 126 - 130 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626813 | HEMGENIX Kit Patient Weight 126 - 130 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626814 | etranacogene dezaparvovec-drlb Kit Patient Weight 131 - 135 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626814 | etranacogene dezaparvovec-drlb Kit Patient Weight 131 - 135 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626814 | etranacogene dezaparvovec-drlb Kit Patient Weight 131 - 135 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626815 | HEMGENIX Kit Patient Weight 131 - 135 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626815 | HEMGENIX Kit Patient Weight 131 - 135 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626815 | HEMGENIX Kit Patient Weight 131 - 135 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626816 | etranacogene dezaparvovec-drlb Kit Patient Weight 136 - 140 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626816 | etranacogene dezaparvovec-drlb Kit Patient Weight 136 - 140 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626816 | etranacogene dezaparvovec-drlb Kit Patient Weight 136 - 140 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626817 | HEMGENIX Kit Patient Weight 136 - 140 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626817 | HEMGENIX Kit Patient Weight 136 - 140 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626817 | HEMGENIX Kit Patient Weight 136 - 140 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626818 | etranacogene dezaparvovec-drlb Kit Patient Weight 141 - 145 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626818 | etranacogene dezaparvovec-drlb Kit Patient Weight 141 - 145 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626818 | etranacogene dezaparvovec-drlb Kit Patient Weight 141 - 145 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626819 | HEMGENIX Kit Patient Weight 141 - 145 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626819 | HEMGENIX Kit Patient Weight 141 - 145 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626819 | HEMGENIX Kit Patient Weight 141 - 145 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626820 | etranacogene dezaparvovec-drlb Kit Patient Weight 236 - 240 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626820 | etranacogene dezaparvovec-drlb Kit Patient Weight 236 - 240 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626820 | etranacogene dezaparvovec-drlb Kit Patient Weight 236 - 240 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626821 | HEMGENIX Kit Patient Weight 236 - 240 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626821 | HEMGENIX Kit Patient Weight 236 - 240 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626821 | HEMGENIX Kit Patient Weight 236 - 240 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626822 | etranacogene dezaparvovec-drlb Kit Patient Weight 231 - 235 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626822 | etranacogene dezaparvovec-drlb Kit Patient Weight 231 - 235 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626822 | etranacogene dezaparvovec-drlb Kit Patient Weight 231 - 235 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626823 | HEMEGENIX Kit Patient Weight 231 - 235 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626823 | HEMEGENIX Kit Patient Weight 231 - 235 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626823 | HEMEGENIX Kit Patient Weight 231 - 235 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626824 | etranacogene dezaparvovec-drlb Kit Patient Weight 226 - 230 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626824 | etranacogene dezaparvovec-drlb Kit Patient Weight 226 - 230 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626824 | etranacogene dezaparvovec-drlb Kit Patient Weight 226 - 230 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626825 | HEMEGENIX Kit Patient Weight 226 - 230 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626825 | HEMEGENIX Kit Patient Weight 226 - 230 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626825 | HEMEGENIX Kit Patient Weight 226 - 230 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626828 | Emzahh 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626828 | Emzahh 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626828 | Emzahh 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626829 | etranacogene dezaparvovec-drlb Kit Patient Weight 146 - 150 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626829 | etranacogene dezaparvovec-drlb Kit Patient Weight 146 - 150 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626829 | etranacogene dezaparvovec-drlb Kit Patient Weight 146 - 150 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626830 | HEMGENIX Kit Patient Weight 146 - 150 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626830 | HEMGENIX Kit Patient Weight 146 - 150 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626830 | HEMGENIX Kit Patient Weight 146 - 150 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626831 | etranacogene dezaparvovec-drlb Kit Patient Weight 151 - 155 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626831 | etranacogene dezaparvovec-drlb Kit Patient Weight 151 - 155 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626831 | etranacogene dezaparvovec-drlb Kit Patient Weight 151 - 155 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626832 | HEMGENIX Kit Patient Weight 151 - 155 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626832 | HEMGENIX Kit Patient Weight 151 - 155 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626832 | HEMGENIX Kit Patient Weight 151 - 155 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626833 | etranacogene dezaparvovec-drlb Kit Patient Weight 156 - 160 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626833 | etranacogene dezaparvovec-drlb Kit Patient Weight 156 - 160 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626833 | etranacogene dezaparvovec-drlb Kit Patient Weight 156 - 160 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626834 | HEMGENIX Kit Patient Weight 156 - 160 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626834 | HEMGENIX Kit Patient Weight 156 - 160 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626834 | HEMGENIX Kit Patient Weight 156 - 160 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626835 | etranacogene dezaparvovec-drlb Kit Patient Weight 161 - 165 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626835 | etranacogene dezaparvovec-drlb Kit Patient Weight 161 - 165 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626835 | etranacogene dezaparvovec-drlb Kit Patient Weight 161 - 165 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626836 | HEMGENIX Kit Patient Weight 161 - 165 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626836 | HEMGENIX Kit Patient Weight 161 - 165 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626836 | HEMGENIX Kit Patient Weight 161 - 165 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626837 | etranacogene dezaparvovec-drlb Kit Patient Weight 166 - 170 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626837 | etranacogene dezaparvovec-drlb Kit Patient Weight 166 - 170 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626837 | etranacogene dezaparvovec-drlb Kit Patient Weight 166 - 170 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626838 | HEMGENIX Kit Patient Weight 166 - 170 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626838 | HEMGENIX Kit Patient Weight 166 - 170 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626838 | HEMGENIX Kit Patient Weight 166 - 170 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626839 | etranacogene dezaparvovec-drlb Kit Patient Weight 171 - 175 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626839 | etranacogene dezaparvovec-drlb Kit Patient Weight 171 - 175 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626839 | etranacogene dezaparvovec-drlb Kit Patient Weight 171 - 175 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626840 | HEMGENIX Kit Patient Weight 171 - 175 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626840 | HEMGENIX Kit Patient Weight 171 - 175 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626840 | HEMGENIX Kit Patient Weight 171 - 175 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626843 | etranacogene dezaparvovec-drlb Kit Patient Weight 181 - 185 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626843 | etranacogene dezaparvovec-drlb Kit Patient Weight 181 - 185 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626843 | etranacogene dezaparvovec-drlb Kit Patient Weight 181 - 185 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626844 | HEMGENIX Kit Patient Weight 181 - 185 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626844 | HEMGENIX Kit Patient Weight 181 - 185 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626844 | HEMGENIX Kit Patient Weight 181 - 185 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626845 | etranacogene dezaparvovec-drlb Kit Patient Weight 186 - 190 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626845 | etranacogene dezaparvovec-drlb Kit Patient Weight 186 - 190 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626845 | etranacogene dezaparvovec-drlb Kit Patient Weight 186 - 190 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626846 | HEMGENIX Kit Patient Weight 186 - 190 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626846 | HEMGENIX Kit Patient Weight 186 - 190 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626846 | HEMGENIX Kit Patient Weight 186 - 190 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626847 | etranacogene dezaparvovec-drlb Kit Patient Weight 191 - 195 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626847 | etranacogene dezaparvovec-drlb Kit Patient Weight 191 - 195 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626847 | etranacogene dezaparvovec-drlb Kit Patient Weight 191 - 195 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626848 | HEMGENIX Kit Patient Weight 191 - 195 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626848 | HEMGENIX Kit Patient Weight 191 - 195 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626848 | HEMGENIX Kit Patient Weight 191 - 195 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626849 | etranacogene dezaparvovec-drlb Kit Patient Weight 221 - 225 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626849 | etranacogene dezaparvovec-drlb Kit Patient Weight 221 - 225 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626849 | etranacogene dezaparvovec-drlb Kit Patient Weight 221 - 225 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626850 | HEMGENIX Kit Patient Weight 221 - 225 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626850 | HEMGENIX Kit Patient Weight 221 - 225 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626850 | HEMGENIX Kit Patient Weight 221 - 225 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626851 | etranacogene dezaparvovec-drlb Kit Patient Weight 216 - 220 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626851 | etranacogene dezaparvovec-drlb Kit Patient Weight 216 - 220 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626851 | etranacogene dezaparvovec-drlb Kit Patient Weight 216 - 220 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626852 | HEMGENIX Kit Patient Weight 216 - 220 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626852 | HEMGENIX Kit Patient Weight 216 - 220 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626852 | HEMGENIX Kit Patient Weight 216 - 220 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626853 | etranacogene dezaparvovec-drlb Kit Patient Weight 211 - 215 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626853 | etranacogene dezaparvovec-drlb Kit Patient Weight 211 - 215 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626853 | etranacogene dezaparvovec-drlb Kit Patient Weight 211 - 215 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626854 | HEMGENIX Kit Patient Weight 211 - 215 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626854 | HEMGENIX Kit Patient Weight 211 - 215 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626854 | HEMGENIX Kit Patient Weight 211 - 215 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626855 | etranacogene dezaparvovec-drlb Kit Patient Weight 206 - 210 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626855 | etranacogene dezaparvovec-drlb Kit Patient Weight 206 - 210 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626855 | etranacogene dezaparvovec-drlb Kit Patient Weight 206 - 210 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626856 | HEMGENIX Kit Patient Weight 206 - 210 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626856 | HEMGENIX Kit Patient Weight 206 - 210 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626856 | HEMGENIX Kit Patient Weight 206 - 210 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626857 | etranacogene dezaparvovec-drlb Kit Patient Weight 201 - 205 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626857 | etranacogene dezaparvovec-drlb Kit Patient Weight 201 - 205 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626857 | etranacogene dezaparvovec-drlb Kit Patient Weight 201 - 205 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626858 | HEMGENIX Kit Patient Weight 201- 205 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626858 | HEMGENIX Kit Patient Weight 201- 205 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626858 | HEMGENIX Kit Patient Weight 201- 205 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626859 | etranacogene dezaparvovec-drlb Kit Patient Weight 196 - 200 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2626859 | etranacogene dezaparvovec-drlb Kit Patient Weight 196 - 200 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626859 | etranacogene dezaparvovec-drlb Kit Patient Weight 196 - 200 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626860 | HEMGENIX Kit Patient Weight 196 - 200 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2626860 | HEMGENIX Kit Patient Weight 196 - 200 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2626860 | HEMGENIX Kit Patient Weight 196 - 200 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2626882 | IPDI - Isophorone di-isocyanate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626882 | IPDI - Isophorone di-isocyanate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2626882 | IPDI - Isophorone di-isocyanate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2626882 | IPDI - Isophorone di-isocyanate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2626882 | IPDI - Isophorone di-isocyanate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2626882 | IPDI - Isophorone di-isocyanate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2626886 | Lactobacillus kefiri | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626886 | Lactobacillus kefiri | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2626911 | loose barley smut allergenic extract 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2626912 | loose barley smut allergenic extract 25 MG/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2626912 | loose barley smut allergenic extract 25 MG/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2626912 | loose barley smut allergenic extract 25 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626912 | loose barley smut allergenic extract 25 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626913 | loose oat smut allergenic extract 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2626914 | loose oat smut extract 25 MG/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2626914 | loose oat smut extract 25 MG/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2626914 | loose oat smut extract 25 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626914 | loose oat smut extract 25 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626916 | minoxidil 20 MG/ML [Head & Shoulders Scalp X] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2626917 | minoxidil Topical Solution [Head & Shoulders Scalp X] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2626918 | Head & Shoulders Scalp X 2 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2626918 | Head & Shoulders Scalp X 2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2626918 | Head & Shoulders Scalp X 2 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2627044 | bexagliflozin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2627045 | bexagliflozin 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2627046 | bexagliflozin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2627047 | bexagliflozin Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2627048 | bexagliflozin Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2627049 | bexagliflozin 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2627049 | bexagliflozin 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2627050 | Bexacat | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2627051 | bexagliflozin 15 MG [Bexacat] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2627052 | Bexacat Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2627053 | Bexacat Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2627054 | bexagliflozin Oral Tablet [Bexacat] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2627055 | Bexacat 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2627055 | Bexacat 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627055 | Bexacat 15 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2627141 | etranacogene dezaparvovec-drlb Kit Patient Weight 176 - 180 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2627141 | etranacogene dezaparvovec-drlb Kit Patient Weight 176 - 180 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2627141 | etranacogene dezaparvovec-drlb Kit Patient Weight 176 - 180 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2627142 | HEMGENIX Kit Patient Weight 176 - 180 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2627142 | HEMGENIX Kit Patient Weight 176 - 180 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2627142 | HEMGENIX Kit Patient Weight 176 - 180 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2627241 | Rhodiola crenulata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2627242 | Strychnos mitis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2627243 | Endothelium-derived relaxation factor-forming enzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627243 | Endothelium-derived relaxation factor-forming enzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627243 | Endothelium-derived relaxation factor-forming enzyme | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2627243 | Endothelium-derived relaxation factor-forming enzyme | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627243 | Endothelium-derived relaxation factor-forming enzyme | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627245 | nitric oxide synthase endothelial | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627245 | nitric oxide synthase endothelial | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2627246 | gekko gecko preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2627247 | Chrysops vittatus whole allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2627248 | Chrysops vittatus whole allergenic extract 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2627249 | Chrysops vittatus whole allergenic extract Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2627250 | Chrysops vittatus whole allergenic extract Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2627251 | Chrysops vittatus whole allergenic extract 1 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2627251 | Chrysops vittatus whole allergenic extract 1 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2627251 | Chrysops vittatus whole allergenic extract 1 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627252 | Chrysops vittatus whole allergenic extract 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2627253 | Chrysops vittatus whole allergenic extract 25 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2627253 | Chrysops vittatus whole allergenic extract 25 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2627253 | Chrysops vittatus whole allergenic extract 25 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627280 | Dioscorea villosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2627281 | urea 395 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2627282 | urea 39.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2627282 | urea 39.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2627282 | urea 39.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2627283 | Opti-Nail | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2627284 | tolnaftate 10 MG/ML [Opti-Nail] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2627285 | Opti-Nail Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2627286 | tolnaftate Topical Solution [Opti-Nail] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2627287 | Opti-Nail 1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2627287 | Opti-Nail 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627287 | Opti-Nail 1 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2627295 | diphenhydramine / hydrocortisone / pramoxine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 2627295 | diphenhydramine / hydrocortisone / pramoxine | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2627296 | diphenhydramine / hydrocortisone / pramoxine Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2627296 | diphenhydramine / hydrocortisone / pramoxine Topical Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2627297 | diphenhydramine / hydrocortisone / pramoxine Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2627297 | diphenhydramine / hydrocortisone / pramoxine Medicated Pad or Tape | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2627298 | diphenhydramine / hydrocortisone / pramoxine Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2627298 | diphenhydramine / hydrocortisone / pramoxine Medicated Pad | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2627299 | diphenhydrAMINE HCl 1 % / hydrocortisone 0.5 % / pramoxine HCl 1 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2627299 | diphenhydrAMINE HCl 1 % / hydrocortisone 0.5 % / pramoxine HCl 1 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627299 | diphenhydrAMINE HCl 1 % / hydrocortisone 0.5 % / pramoxine HCl 1 % Medicated Pad | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2627299 | diphenhydrAMINE HCl 1 % / hydrocortisone 0.5 % / pramoxine HCl 1 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2627299 | diphenhydrAMINE HCl 1 % / hydrocortisone 0.5 % / pramoxine HCl 1 % Medicated Pad | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2627300 | 3-phenyl propionic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2627301 | dimethicone 0.28 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2627302 | dimethicone 28 % / petrolatum 48 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2627302 | dimethicone 28 % / petrolatum 48 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2627302 | dimethicone 28 % / petrolatum 48 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627373 | Detomised | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2627374 | detomidine hydrochloride 10 MG/ML [Detomised] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2627375 | Detomised Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2627376 | detomidine Injectable Solution [Detomised] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2627377 | DetomiSed 10 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2627377 | DetomiSed 10 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2627377 | DetomiSed 10 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627378 | manganese bromide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2627379 | manganese iodide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 262738 | Clinium | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 26274 | Grotan BK (in water) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 262743 | Phenantoin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 262759 | econazole nitrate 10 MG/ML Topical Cream [Pevaryl] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 262759 | econazole nitrate 10 MG/ML Topical Cream [Pevaryl] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 262761 | econazole nitrate 10 MG/ML Topical Cream [Ecostatin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 262761 | econazole nitrate 10 MG/ML Topical Cream [Ecostatin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627646 | nicotinate ethanolamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2627647 | salicylic acid 1.8 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2627647 | salicylic acid 1.8 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627647 | salicylic acid 1.8 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2627648 | bevacizumab-adcd | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2627649 | bevacizumab-adcd 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2627650 | bevacizumab-adcd 100 MG in 4 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2627650 | bevacizumab-adcd 100 MG in 4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2627650 | bevacizumab-adcd 100 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2627651 | bevacizumab-adcd 25 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2627651 | bevacizumab-adcd 25 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2627651 | bevacizumab-adcd 25 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627652 | Vegzelma | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2627653 | bevacizumab-adcd 25 MG/ML [Vegzelma] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2627654 | Vegzelma Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2627655 | bevacizumab Injection [Vegzelma] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2627656 | Vegzelma 100 MG in 4 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2627656 | Vegzelma 100 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2627656 | Vegzelma 100 MG in 4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2627656 | Vegzelma 100 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2627657 | Vegzelma 25 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2627657 | Vegzelma 25 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2627657 | Vegzelma 25 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627658 | bevacizumab-adcd 400 MG in 16 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2627658 | bevacizumab-adcd 400 MG in 16 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2627658 | bevacizumab-adcd 400 MG in 16 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2627659 | Vegzelma 400 MG in 16 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2627659 | Vegzelma 400 MG in 16 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2627659 | Vegzelma 400 MG in 16 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2627659 | Vegzelma 400 MG in 16 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2627710 | adalimumab-atto 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2627711 | adalimumab-atto 20 MG in 0.4 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2627711 | adalimumab-atto 20 MG in 0.4 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2627711 | adalimumab-atto 20 MG in 0.4 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2627712 | adalimumab-atto 50 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2627712 | adalimumab-atto 50 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2627713 | Amjevita | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2627714 | adalimumab-atto 50 MG/ML [Amjevita] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2627715 | Amjevita Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2627716 | adalimumab Prefilled Syringe [Amjevita] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2627717 | AMJEVITA 20 MG in 0.4 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2627717 | AMJEVITA 20 MG in 0.4 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2627717 | AMJEVITA 20 MG in 0.4 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2627717 | AMJEVITA 20 MG in 0.4 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2627718 | adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2627718 | adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627719 | adalimumab-atto 40 MG in 0.8 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2627719 | adalimumab-atto 40 MG in 0.8 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2627719 | adalimumab-atto 40 MG in 0.8 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 262772 | idoxuridine 50 MG/ML Topical Solution [Iduridin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 262772 | idoxuridine 50 MG/ML Topical Solution [Iduridin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627720 | adalimumab-atto 50 MG/ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2627720 | adalimumab-atto 50 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2627721 | adalimumab Auto-Injector [Amjevita] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2627722 | AMJEVITA 40 MG in 0.8 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2627722 | AMJEVITA 40 MG in 0.8 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2627722 | AMJEVITA 40 MG in 0.8 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2627722 | AMJEVITA 40 MG in 0.8 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2627723 | adalimumab-atto 50 MG/ML Auto-Injector [Amjevita] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2627723 | adalimumab-atto 50 MG/ML Auto-Injector [Amjevita] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627724 | adalimumab-atto 40 MG in 0.8 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2627724 | adalimumab-atto 40 MG in 0.8 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2627724 | adalimumab-atto 40 MG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2627725 | AMJEVITA 40 MG in 0.8 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2627725 | AMJEVITA 40 MG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2627725 | AMJEVITA 40 MG in 0.8 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2627725 | AMJEVITA 40 MG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2627726 | benzethonium chloride 2 MG/ML / benzocaine 150 MG/ML [Dermoplast Antibacterial] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2627727 | Dermoplast Antiseptic Kids 0.2 % / 15 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2627727 | Dermoplast Antiseptic Kids 0.2 % / 15 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627727 | Dermoplast Antiseptic Kids 0.2 % / 15 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2627728 | Pneumococcal 20-valent conjugate vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627728 | Pneumococcal 20-valent conjugate vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627728 | Pneumococcal 20-valent conjugate vaccine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627728 | Pneumococcal 20-valent conjugate vaccine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627730 | Product containing only tasonermin in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627730 | Product containing only tasonermin in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627731 | Aceclofenac and thiocolchicoside only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627731 | Aceclofenac and thiocolchicoside only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627732 | Aceclofenac and thiocolchicoside only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627732 | Aceclofenac and thiocolchicoside only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627733 | Aluminium chloride and isopropyl alcohol only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627733 | Aluminium chloride and isopropyl alcohol only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627733 | Aluminium chloride and isopropyl alcohol only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627734 | Aluminium chloride and isopropyl alcohol only product in cutaneous dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627734 | Aluminium chloride and isopropyl alcohol only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627734 | Aluminium chloride and isopropyl alcohol only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627735 | Cannabidiol and delta-9-tetrahydrocannabinol only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627735 | Cannabidiol and delta-9-tetrahydrocannabinol only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627736 | Cannabidiol and delta-9-tetrahydrocannabinol only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627736 | Cannabidiol and delta-9-tetrahydrocannabinol only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627737 | Cefixime and ofloxacin only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627737 | Cefixime and ofloxacin only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627738 | Cefixime and ofloxacin only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627738 | Cefixime and ofloxacin only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627739 | Chlorhexidine and tetracaine only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627739 | Chlorhexidine and tetracaine only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 262774 | SN 105-843 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627740 | Domperidone and rabeprazole only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627740 | Domperidone and rabeprazole only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627741 | Domperidone and rabeprazole only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627741 | Domperidone and rabeprazole only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627742 | Levamlodipine and metoprolol only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627742 | Levamlodipine and metoprolol only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627743 | Levamlodipine and metoprolol only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627743 | Levamlodipine and metoprolol only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627744 | Measles and mumps vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627744 | Measles and mumps vaccine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627744 | Measles and mumps vaccine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627745 | Mucin only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627745 | Mucin only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627746 | Product containing only recombinant parathyroid hormone in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627746 | Product containing only recombinant parathyroid hormone in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627747 | Product containing only regadenoson in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627747 | Product containing only regadenoson in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627748 | Meningococcus serogroup A vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627748 | Meningococcus serogroup A vaccine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627748 | Meningococcus serogroup A vaccine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627749 | Benzathine benzylpenicillin and procaine benzylpenicillin only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627749 | Benzathine benzylpenicillin and procaine benzylpenicillin only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627749 | Benzathine benzylpenicillin and procaine benzylpenicillin only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627750 | Benzathine benzylpenicillin and procaine benzylpenicillin only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627750 | Benzathine benzylpenicillin and procaine benzylpenicillin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627750 | Benzathine benzylpenicillin and procaine benzylpenicillin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627780 | metaxalone 640 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2627781 | metaxalone 640 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2627781 | metaxalone 640 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2627782 | sodium adipate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2627783 | naphazoline / propylene glycol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 2627784 | naphazoline / propylene glycol Ophthalmic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2627785 | naphazoline / propylene glycol Ophthalmic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2627786 | naphazoline hydrochloride 0.03 % / propylene glycol 1 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2627786 | naphazoline hydrochloride 0.03 % / propylene glycol 1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627786 | naphazoline hydrochloride 0.03 % / propylene glycol 1 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2627787 | Aceclofenac 100 mg and thiocolchicoside 4 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627787 | Aceclofenac 100 mg and thiocolchicoside 4 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627788 | Aceclofenac 100 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627788 | Aceclofenac 100 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627789 | Paracetamol 10 mg/mL solution for infusion | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627789 | Paracetamol 10 mg/mL solution for infusion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627789 | Paracetamol 10 mg/mL solution for infusion | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627790 | Paracetamol 10 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627790 | Paracetamol 10 mg/mL solution for infusion and/or injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627790 | Paracetamol 10 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627791 | Mefenamic acid 500 mg and paracetamol 500 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627791 | Mefenamic acid 500 mg and paracetamol 500 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627791 | Mefenamic acid 500 mg and paracetamol 500 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627792 | Aluminium chloride 350 mg/mL and isopropyl alcohol 325 mg/mL cutaneous solution | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 2627792 | Aluminium chloride 350 mg/mL and isopropyl alcohol 325 mg/mL cutaneous solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627792 | Aluminium chloride 350 mg/mL and isopropyl alcohol 325 mg/mL cutaneous solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627793 | Anhydrous glucose 40 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 1.8 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627793 | Anhydrous glucose 40 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 1.8 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627794 | Anhydrous glucose 40 mg/mL and potassium chloride 2 mg/mL and sodium chloride 1.8 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627794 | Anhydrous glucose 40 mg/mL and potassium chloride 2 mg/mL and sodium chloride 1.8 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627795 | Anhydrous glucose 40 mg/mL and potassium chloride 3 mg/mL and sodium chloride 1.8 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627795 | Anhydrous glucose 40 mg/mL and potassium chloride 3 mg/mL and sodium chloride 1.8 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627796 | Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 4.5 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627796 | Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 4.5 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627797 | Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627797 | Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627798 | Anhydrous glucose 50 mg/mL and potassium chloride 2 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627798 | Anhydrous glucose 50 mg/mL and potassium chloride 2 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627799 | Anhydrous glucose 50 mg/mL and potassium chloride 3 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627799 | Anhydrous glucose 50 mg/mL and potassium chloride 3 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627801 | Baclofen 10 mg prolonged-release oral capsule | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627801 | Baclofen 10 mg prolonged-release oral capsule | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627802 | Cannabidiol 25 mg/mL and delta-9-tetrahydrocannabinol 27 mg/mL oromucosal spray | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627802 | Cannabidiol 25 mg/mL and delta-9-tetrahydrocannabinol 27 mg/mL oromucosal spray | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627803 | Cefixime 100 mg and ofloxacin 100 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627803 | Cefixime 100 mg and ofloxacin 100 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627804 | Chloramphenicol 10 mg/mL and dexamethasone sodium phosphate 1 mg/mL ear or eye drops | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627804 | Chloramphenicol 10 mg/mL and dexamethasone sodium phosphate 1 mg/mL ear or eye drops | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627805 | Cladribine 2 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627805 | Cladribine 2 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627806 | Coal tar 60 mg/g and salicylic acid 30 mg/g cutaneous ointment | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627806 | Coal tar 60 mg/g and salicylic acid 30 mg/g cutaneous ointment | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627807 | Domperidone 10 mg and pantoprazole (as pantoprazole sodium) 20 mg gastro-resistant oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627807 | Domperidone 10 mg and pantoprazole (as pantoprazole sodium) 20 mg gastro-resistant oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627808 | Domperidone 30 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral capsule | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627808 | Domperidone 30 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral capsule | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627809 | Adrenaline 1.667 mg/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627809 | Adrenaline 1.667 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627809 | Adrenaline 1.667 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627810 | Ferrous fumarate 28 mg/mL oral suspension | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627810 | Ferrous fumarate 28 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627811 | Gemtuzumab ozogamicin 5 mg powder for solution for infusion and/or injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627811 | Gemtuzumab ozogamicin 5 mg powder for solution for infusion and/or injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627812 | Gemtuzumab ozogamicin 5 mg powder for solution for infusion vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627812 | Gemtuzumab ozogamicin 5 mg powder for solution for infusion vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627813 | Ibuprofen 100 mg chewable soft capsule | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627813 | Ibuprofen 100 mg chewable soft capsule | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627814 | Infliximab 100 mg powder for solution for infusion and/or injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627814 | Infliximab 100 mg powder for solution for infusion and/or injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627815 | Infliximab 100 mg powder for solution for infusion vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627815 | Infliximab 100 mg powder for solution for infusion vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627816 | Inotuzumab ozogamicin 1 mg powder for solution for infusion vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627816 | Inotuzumab ozogamicin 1 mg powder for solution for infusion vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627817 | Itraconazole 200 mg oral capsule | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627817 | Itraconazole 200 mg oral capsule | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627818 | Leuprolide acetate 11.25 mg powder for prolonged-release suspension for injection syringe | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627818 | Leuprolide acetate 11.25 mg powder for prolonged-release suspension for injection syringe | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627822 | rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 667000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2627823 | rotavirus, live attenuated (RV1) G1P[8] Oral Vaccine 1.5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2627823 | rotavirus, live attenuated (RV1) G1P[8] Oral Vaccine 1.5 ML Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2627823 | rotavirus, live attenuated (RV1) G1P[8] Oral Vaccine 1.5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2627824 | rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 667000 UNT/ML [Rotarix] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2627825 | Rotarix, Rotavirus, live attenuated (RV1) G1P[8] Vaccine 1.5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2627825 | Rotarix, Rotavirus, live attenuated (RV1) G1P[8] Vaccine 1.5 ML Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2627825 | Rotarix, Rotavirus, live attenuated (RV1) G1P[8] Vaccine 1.5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2627825 | Rotarix, Rotavirus, live attenuated (RV1) G1P[8] Vaccine 1.5 ML Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2627886 | Leuprorelin acetate 3.75 mg powder for suspension for injection syringe | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627886 | Leuprorelin acetate 3.75 mg powder for suspension for injection syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627886 | Leuprorelin acetate 3.75 mg powder for suspension for injection syringe | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627888 | Leuprorelin acetate 30 mg powder for prolonged-release suspension for injection syringe | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627888 | Leuprorelin acetate 30 mg powder for prolonged-release suspension for injection syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627888 | Leuprorelin acetate 30 mg powder for prolonged-release suspension for injection syringe | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627889 | Leuprorelin acetate 45 mg powder for solution for injection syringe | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627889 | Leuprorelin acetate 45 mg powder for solution for injection syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627889 | Leuprorelin acetate 45 mg powder for solution for injection syringe | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627891 | Leuprorelin acetate 7.5 mg powder for suspension for injection syringe | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627891 | Leuprorelin acetate 7.5 mg powder for suspension for injection syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627891 | Leuprorelin acetate 7.5 mg powder for suspension for injection syringe | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627892 | Levamlodipine (as levamlodipine besilate) 2.5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627892 | Levamlodipine (as levamlodipine besilate) 2.5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627892 | Levamlodipine (as levamlodipine besilate) 2.5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627893 | Levamlodipine (as levamlodipine besilate) 5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627893 | Levamlodipine (as levamlodipine besilate) 5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627893 | Levamlodipine (as levamlodipine besilate) 5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627894 | Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627894 | Levocetirizine dihydrochloride 2.5 mg and montelukast (as montelukast sodium) 4 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627895 | Lornoxicam 16 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627895 | Lornoxicam 16 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627896 | Magnesium (as magnesium aspartate) 243 mg powder for oral solution sachet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627896 | Magnesium (as magnesium aspartate) 243 mg powder for oral solution sachet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627897 | Methotrexate (as methotrexate sodium) 50 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627897 | Methotrexate (as methotrexate sodium) 50 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627898 | Naloxone (as naloxone hydrochloride) 1.8 mg/actuation nasal spray | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627898 | Naloxone (as naloxone hydrochloride) 1.8 mg/actuation nasal spray | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627899 | Ofatumumab 50 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627899 | Ofatumumab 50 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627903 | Product containing precisely quetiapine (as quetiapine fumarate) 20 milligram/1 milliliter conventional release oral suspension (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627903 | Product containing precisely quetiapine (as quetiapine fumarate) 20 milligram/1 milliliter conventional release oral suspension (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627904 | Product containing precisely recombinant parathyroid hormone 1.05 milligram/1 cartridge powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627904 | Product containing precisely recombinant parathyroid hormone 1.05 milligram/1 cartridge powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627905 | Product containing precisely recombinant parathyroid hormone 1.4 milligram/1 cartridge powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627905 | Product containing precisely recombinant parathyroid hormone 1.4 milligram/1 cartridge powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627906 | Product containing precisely risankizumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627906 | Product containing precisely risankizumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627907 | Product containing precisely risankizumab 90.361 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627907 | Product containing precisely risankizumab 90.361 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627908 | Product containing precisely romosozumab 90 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627908 | Product containing precisely romosozumab 90 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627909 | Product containing precisely sodium bicarbonate 84 milligram/1 milliliter conventional release solution for infusion (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627909 | Product containing precisely sodium bicarbonate 84 milligram/1 milliliter conventional release solution for infusion (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627910 | Product containing precisely sodium bicarbonate 84 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627910 | Product containing precisely sodium bicarbonate 84 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627911 | Product containing precisely somatropin 1 milligram/1 cartridge powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627911 | Product containing precisely somatropin 1 milligram/1 cartridge powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627912 | Product containing precisely somatropin 1.2 milligram/1 cartridge powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627912 | Product containing precisely somatropin 1.2 milligram/1 cartridge powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627913 | Product containing precisely somatropin 1.4 milligram/1 cartridge powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627913 | Product containing precisely somatropin 1.4 milligram/1 cartridge powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627914 | Product containing precisely somatropin 1.6 milligram/1 cartridge powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627914 | Product containing precisely somatropin 1.6 milligram/1 cartridge powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627915 | Product containing precisely somatropin 1.8 milligram/1 cartridge powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627915 | Product containing precisely somatropin 1.8 milligram/1 cartridge powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627916 | Product containing precisely somatropin 2 milligram/1 cartridge powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627916 | Product containing precisely somatropin 2 milligram/1 cartridge powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627917 | Product containing precisely somatropin 5.3 milligram/1 cartridge powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627917 | Product containing precisely somatropin 5.3 milligram/1 cartridge powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627918 | Suxamethonium chloride 10 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627918 | Suxamethonium chloride 10 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627918 | Suxamethonium chloride 10 mg/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627919 | Product containing precisely tasonermin 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627919 | Product containing precisely tasonermin 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627920 | Product containing precisely teduglutide 1.25 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627920 | Product containing precisely teduglutide 1.25 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627921 | Product containing precisely terlipressin acetate 1 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627921 | Product containing precisely terlipressin acetate 1 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627922 | Product containing precisely thiotepa 400 milligram/1 bag powder for conventional release solution for infusion (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627922 | Product containing precisely thiotepa 400 milligram/1 bag powder for conventional release solution for infusion (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627923 | Product containing precisely topotecan (as topotecan hydrochloride) 1 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627923 | Product containing precisely topotecan (as topotecan hydrochloride) 1 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627925 | Product containing precisely topotecan (as topotecan hydrochloride) 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627925 | Product containing precisely topotecan (as topotecan hydrochloride) 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627926 | Product containing precisely trastuzumab 420 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627926 | Product containing precisely trastuzumab 420 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627927 | Product containing precisely trastuzumab 60 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627927 | Product containing precisely trastuzumab 60 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627928 | Product containing precisely trastuzumab 60 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627928 | Product containing precisely trastuzumab 60 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627929 | Product containing precisely trastuzumab deruxtecan 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627929 | Product containing precisely trastuzumab deruxtecan 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627930 | Product containing precisely vedolizumab 158.824 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627930 | Product containing precisely vedolizumab 158.824 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627931 | (S)-metoprolol | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627931 | (S)-metoprolol | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627932 | (S)-metoprolol succinate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627932 | (S)-metoprolol succinate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627933 | (S)-metoprolol tartrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627933 | (S)-metoprolol tartrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627934 | Aceclofenac- and thiocolchicoside-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627934 | Aceclofenac- and thiocolchicoside-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627935 | Aceclofenac- and thiocolchicoside-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627935 | Aceclofenac- and thiocolchicoside-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627936 | Apis mellifera scutellata venom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627936 | Apis mellifera scutellata venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627936 | Apis mellifera scutellata venom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627937 | Alendronic acid (as alendronate sodium) 700 microgram/mL oral solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627937 | Alendronic acid (as alendronate sodium) 700 microgram/mL oral solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627938 | Aluminium chloride- and isopropyl alcohol-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627938 | Aluminium chloride- and isopropyl alcohol-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627938 | Aluminium chloride- and isopropyl alcohol-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627939 | Aluminium chloride- and isopropyl alcohol-containing product in cutaneous dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627939 | Aluminium chloride- and isopropyl alcohol-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627939 | Aluminium chloride- and isopropyl alcohol-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627941 | Hapalochlaena venom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627941 | Hapalochlaena venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627941 | Hapalochlaena venom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627942 | Cannabidiol- and delta-9-tetrahydrocannabinol-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627942 | Cannabidiol- and delta-9-tetrahydrocannabinol-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627943 | Cannabidiol- and delta-9-tetrahydrocannabinol-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627943 | Cannabidiol- and delta-9-tetrahydrocannabinol-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627944 | Lepidoptera larva venom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627944 | Lepidoptera larva venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627944 | Lepidoptera larva venom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627945 | Cefixime- and ofloxacin-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627945 | Cefixime- and ofloxacin-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627946 | Cefixime- and ofloxacin-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627946 | Cefixime- and ofloxacin-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627947 | Centrally acting antiobesity agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627947 | Centrally acting antiobesity agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627948 | Bufo alvarius toxin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627948 | Bufo alvarius toxin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627948 | Bufo alvarius toxin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627950 | Cone shell venom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627950 | Cone shell venom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627953 | Domperidone- and rabeprazole-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627953 | Domperidone- and rabeprazole-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627954 | Domperidone- and rabeprazole-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627954 | Domperidone- and rabeprazole-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627955 | Bothrops atrox venom (substance) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627955 | Bothrops atrox venom (substance) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627956 | Flucloxacillin (as flucloxacillin sodium) 1 g powder for solution for infusion and/or injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627956 | Flucloxacillin (as flucloxacillin sodium) 1 g powder for solution for infusion and/or injection vial | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627956 | Flucloxacillin (as flucloxacillin sodium) 1 g powder for solution for infusion and/or injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627957 | Fluticasone propionate 250 microgram/mL suspension for nebuliser | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 2627957 | Fluticasone propionate 250 microgram/mL suspension for nebuliser | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627957 | Fluticasone propionate 250 microgram/mL suspension for nebuliser | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627958 | Glycopyrronium (as glycopyrronium bromide) 160 microgram/mL oral solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627958 | Glycopyrronium (as glycopyrronium bromide) 160 microgram/mL oral solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2627958 | Glycopyrronium (as glycopyrronium bromide) 160 microgram/mL oral solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627959 | Green coffee bean | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627959 | Green coffee bean | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627960 | Heparin ammonium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627960 | Heparin ammonium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627961 | Heparin lithium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627961 | Heparin lithium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627962 | Hyaluronidase 1500 unit powder for solution for infusion and/or injection ampoule | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 2627962 | Hyaluronidase 1500 unit powder for solution for infusion and/or injection ampoule | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627962 | Hyaluronidase 1500 unit powder for solution for infusion and/or injection ampoule | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2627963 | Ifosfamide 2 g powder for solution for infusion and/or injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2627963 | Ifosfamide 2 g powder for solution for infusion and/or injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628141 | Levamlodipine- and metoprolol-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628141 | Levamlodipine- and metoprolol-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628142 | Levamlodipine- and metoprolol-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628142 | Levamlodipine- and metoprolol-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628143 | Levothyroxine sodium 10 microgram/mL oral solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628143 | Levothyroxine sodium 10 microgram/mL oral solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628144 | Levothyroxine sodium 5 microgram/mL oral solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628144 | Levothyroxine sodium 5 microgram/mL oral solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628145 | Pterois venom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628145 | Pterois venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628145 | Pterois venom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628146 | Antigen of live attenuated virus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628146 | Antigen of live attenuated virus | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628146 | Antigen of live attenuated virus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628146 | Antigen of live attenuated virus | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628147 | Live attenuated virus antigen-containing vaccine product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628147 | Live attenuated virus antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628148 | Lophyrotoma interrupta larva venom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628148 | Lophyrotoma interrupta larva venom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628149 | Bufo marinus toxin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628149 | Bufo marinus toxin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628149 | Bufo marinus toxin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628150 | Mesalamine 1.2 g prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628150 | Mesalamine 1.2 g prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628152 | Normal human immunoglobulin 10 g powder for solution for infusion vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628152 | Normal human immunoglobulin 10 g powder for solution for infusion vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628153 | Octocog alfa 1000 international unit powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628153 | Octocog alfa 1000 international unit powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628154 | Octocog alfa 2000 international unit powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628154 | Octocog alfa 2000 international unit powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628155 | Octopoda venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628155 | Octopoda venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628155 | Octopoda venom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628155 | Octopoda venom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628156 | Benzathine benzylpenicillin- and procaine benzylpenicillin-containing product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628156 | Benzathine benzylpenicillin- and procaine benzylpenicillin-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628156 | Benzathine benzylpenicillin- and procaine benzylpenicillin-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628159 | Megalopyge opercularis larva venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628159 | Megalopyge opercularis larva venom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628159 | Megalopyge opercularis larva venom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628160 | Product containing precisely ramipril 500 microgram/1 milliliter conventional release oral solution (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628160 | Product containing precisely ramipril 500 microgram/1 milliliter conventional release oral solution (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628161 | Rear-fanged snake venom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628161 | Rear-fanged snake venom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628162 | Product containing precisely recombinant parathyroid hormone 350 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628162 | Product containing precisely recombinant parathyroid hormone 350 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628163 | Product containing precisely recombinant parathyroid hormone 700 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628163 | Product containing precisely recombinant parathyroid hormone 700 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628164 | Product containing recombinant parathyroid hormone in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628164 | Product containing recombinant parathyroid hormone in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628166 | Product containing regadenoson in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628166 | Product containing regadenoson in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628167 | Tenthredinoidea larva venom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628167 | Tenthredinoidea larva venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628167 | Tenthredinoidea larva venom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628169 | Holothuroidea venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628169 | Holothuroidea venom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628169 | Holothuroidea venom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628170 | Echinoidea venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628170 | Echinoidea venom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628170 | Echinoidea venom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628171 | Product containing precisely somatropin 200 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628171 | Product containing precisely somatropin 200 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628172 | Product containing precisely somatropin 400 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628172 | Product containing precisely somatropin 400 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628173 | Product containing precisely somatropin 600 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628173 | Product containing precisely somatropin 600 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628174 | Product containing precisely somatropin 800 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628174 | Product containing precisely somatropin 800 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628175 | Glycine max dust | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628175 | Glycine max dust | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628175 | Glycine max dust | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628175 | Glycine max dust | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628176 | Myliobatiformes venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628176 | Myliobatiformes venom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628176 | Myliobatiformes venom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628177 | Leptosynanceia asteroblepa venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628177 | Leptosynanceia asteroblepa venom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628177 | Leptosynanceia asteroblepa venom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628178 | Antigen of Streptococcus pneumoniae Danish serotype 10A capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628178 | Antigen of Streptococcus pneumoniae Danish serotype 10A capsular polysaccharide conjugated | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628178 | Antigen of Streptococcus pneumoniae Danish serotype 10A capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628178 | Antigen of Streptococcus pneumoniae Danish serotype 10A capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628178 | Antigen of Streptococcus pneumoniae Danish serotype 10A capsular polysaccharide conjugated | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628179 | Antigen of Streptococcus pneumoniae Danish serotype 11A capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628179 | Antigen of Streptococcus pneumoniae Danish serotype 11A capsular polysaccharide conjugated | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628179 | Antigen of Streptococcus pneumoniae Danish serotype 11A capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628179 | Antigen of Streptococcus pneumoniae Danish serotype 11A capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628179 | Antigen of Streptococcus pneumoniae Danish serotype 11A capsular polysaccharide conjugated | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628180 | Antigen of Streptococcus pneumoniae Danish serotype 12F capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628180 | Antigen of Streptococcus pneumoniae Danish serotype 12F capsular polysaccharide conjugated | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628180 | Antigen of Streptococcus pneumoniae Danish serotype 12F capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628180 | Antigen of Streptococcus pneumoniae Danish serotype 12F capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628180 | Antigen of Streptococcus pneumoniae Danish serotype 12F capsular polysaccharide conjugated | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628181 | Antigen of Streptococcus pneumoniae Danish serotype 15B capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628181 | Antigen of Streptococcus pneumoniae Danish serotype 15B capsular polysaccharide conjugated | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628181 | Antigen of Streptococcus pneumoniae Danish serotype 15B capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628181 | Antigen of Streptococcus pneumoniae Danish serotype 15B capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628181 | Antigen of Streptococcus pneumoniae Danish serotype 15B capsular polysaccharide conjugated | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628182 | Antigen of Streptococcus pneumoniae Danish serotype 22F capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628182 | Antigen of Streptococcus pneumoniae Danish serotype 22F capsular polysaccharide conjugated | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628182 | Antigen of Streptococcus pneumoniae Danish serotype 22F capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628182 | Antigen of Streptococcus pneumoniae Danish serotype 22F capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628182 | Antigen of Streptococcus pneumoniae Danish serotype 22F capsular polysaccharide conjugated | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628183 | Antigen of Streptococcus pneumoniae Danish serotype 33F capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628183 | Antigen of Streptococcus pneumoniae Danish serotype 33F capsular polysaccharide conjugated | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628183 | Antigen of Streptococcus pneumoniae Danish serotype 33F capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628183 | Antigen of Streptococcus pneumoniae Danish serotype 33F capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628183 | Antigen of Streptococcus pneumoniae Danish serotype 33F capsular polysaccharide conjugated | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628184 | Antigen of Streptococcus pneumoniae Danish serotype 8 capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628184 | Antigen of Streptococcus pneumoniae Danish serotype 8 capsular polysaccharide conjugated | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628184 | Antigen of Streptococcus pneumoniae Danish serotype 8 capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628184 | Antigen of Streptococcus pneumoniae Danish serotype 8 capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628184 | Antigen of Streptococcus pneumoniae Danish serotype 8 capsular polysaccharide conjugated | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628185 | Product containing precisely trabectedin 250 microgram/1 vial powder for conventional release solution for infusion (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628185 | Product containing precisely trabectedin 250 microgram/1 vial powder for conventional release solution for infusion (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628186 | Viperinae venom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628186 | Viperinae venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628186 | Viperinae venom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628187 | Trachinidae venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628187 | Trachinidae venom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628187 | Trachinidae venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628187 | Trachinidae venom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628188 | Product containing precisely ziconotide (as ziconotide acetate) 100 microgram/1 milliliter conventional release solution for infusion (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628188 | Product containing precisely ziconotide (as ziconotide acetate) 100 microgram/1 milliliter conventional release solution for infusion (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628189 | Product containing precisely ziconotide (as ziconotide acetate) 100 microgram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2628189 | Product containing precisely ziconotide (as ziconotide acetate) 100 microgram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628190 | futibatinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2628191 | futibatinib 4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2628192 | futibatinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2628193 | futibatinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2628194 | futibatinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2628195 | futibatinib 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628195 | futibatinib 4 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2628196 | Lytgobi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2628197 | futibatinib 4 MG [Lytgobi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2628198 | Lytgobi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2628199 | Lytgobi Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2628200 | futibatinib Oral Tablet [Lytgobi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2628201 | LYTGOBI 4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2628201 | LYTGOBI 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628201 | LYTGOBI 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2628203 | futibatinib 4 MG (21) Oral Tablet, 12 MG Daily Dose Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2628203 | futibatinib 4 MG (21) Oral Tablet, 12 MG Daily Dose Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628203 | futibatinib 4 MG (21) Oral Tablet, 12 MG Daily Dose Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2628204 | LYTGOBI 12 MG Daily Dose | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2628204 | LYTGOBI 12 MG Daily Dose | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628204 | LYTGOBI 12 MG Daily Dose | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2628205 | futibatinib 4 MG (28) Oral Tablet, 16 MG Daily Dose Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2628205 | futibatinib 4 MG (28) Oral Tablet, 16 MG Daily Dose Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628205 | futibatinib 4 MG (28) Oral Tablet, 16 MG Daily Dose Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2628206 | LYTGOBI 16 MG Daily Dose | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2628206 | LYTGOBI 16 MG Daily Dose | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628206 | LYTGOBI 16 MG Daily Dose | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2628207 | futibatinib 4 MG (35) Oral Tablet, 20 MG Daily Dose Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2628207 | futibatinib 4 MG (35) Oral Tablet, 20 MG Daily Dose Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628207 | futibatinib 4 MG (35) Oral Tablet, 20 MG Daily Dose Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2628208 | LYTGOBI 20 MG Daily Dose | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2628208 | LYTGOBI 20 MG Daily Dose | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628208 | LYTGOBI 20 MG Daily Dose | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2628210 | daprodustat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2628211 | daprodustat 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2628212 | daprodustat Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2628213 | daprodustat Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2628214 | daprodustat Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2628215 | daprodustat 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628215 | daprodustat 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2628216 | Jesduvroq | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2628217 | daprodustat 1 MG [Jesduvroq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2628218 | Jesduvroq Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2628219 | Jesduvroq Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2628220 | daprodustat Oral Tablet [Jesduvroq] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2628221 | Jesduvroq 1 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2628221 | Jesduvroq 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628221 | Jesduvroq 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2628222 | daprodustat 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2628223 | daprodustat 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628223 | daprodustat 2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2628224 | daprodustat 2 MG [Jesduvroq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2628225 | Jesduvroq 2 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2628225 | Jesduvroq 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628225 | Jesduvroq 2 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2628226 | daprodustat 4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2628227 | daprodustat 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628227 | daprodustat 4 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2628228 | daprodustat 4 MG [Jesduvroq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2628229 | Jesduvroq 4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2628229 | Jesduvroq 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628229 | Jesduvroq 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2628230 | daprodustat 6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2628231 | daprodustat 6 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628231 | daprodustat 6 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2628232 | daprodustat 6 MG [Jesduvroq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2628233 | Jesduvroq 6 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2628233 | Jesduvroq 6 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628233 | Jesduvroq 6 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2628234 | daprodustat 8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2628235 | daprodustat 8 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628235 | daprodustat 8 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2628236 | daprodustat 8 MG [Jesduvroq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2628237 | Jesduvroq 8 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2628237 | Jesduvroq 8 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628237 | Jesduvroq 8 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2628238 | camphor 2 % / menthol 8 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2628238 | camphor 2 % / menthol 8 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628238 | camphor 2 % / menthol 8 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2628239 | sotorasib 320 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2628240 | sotorasib 320 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628240 | sotorasib 320 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2628241 | sotorasib 320 MG [Lumakras] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2628242 | LUMAKRAS 320 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628242 | LUMAKRAS 320 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2628242 | LUMAKRAS 320 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2628243 | menthol Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2628244 | menthol Buccal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2628245 | menthol Buccal Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2628246 | menthol 2.5 MG Buccal Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2628246 | menthol 2.5 MG Buccal Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2628326 | Gigartina skottsbergii | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2628469 | elacestrant | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2628473 | elacestrant dihydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2628474 | elacestrant 86 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2628475 | elacestrant Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2628476 | elacestrant Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2628477 | elacestrant Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2628478 | elacestrant 86 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2628478 | elacestrant 86 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628478 | elacestrant 86 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2628479 | Orserdu | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2628480 | elacestrant 86 MG [Orserdu] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2628481 | Orserdu Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2628482 | Orserdu Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2628483 | elacestrant Oral Tablet [Orserdu] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2628484 | Orserdu 86 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2628484 | Orserdu 86 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628484 | Orserdu 86 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2628486 | elacestrant 345 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2628487 | elacestrant 345 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2628487 | elacestrant 345 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628487 | elacestrant 345 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2628488 | elacestrant 345 MG [Orserdu] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2628489 | Orserdu 345 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2628489 | Orserdu 345 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628489 | Orserdu 345 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2628557 | Fluoride ion (as sodium fluoride) 29 mg/g toothpaste | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2628557 | Fluoride ion (as sodium fluoride) 29 mg/g toothpaste | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 26288 | guaiacolsulfonic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2628919 | tezepelumab Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2628920 | tezepelumab-ekko 210 MG in 1.91 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2628920 | tezepelumab-ekko 210 MG in 1.91 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628920 | tezepelumab-ekko 210 MG in 1.91 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2628921 | tezepelumab-ekko 110 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2628922 | tezepelumab Auto-Injector [Tezspire] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2628923 | Tezspire 210 MG in 1.91 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2628923 | Tezspire 210 MG in 1.91 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2628923 | Tezspire 210 MG in 1.91 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628923 | Tezspire 210 MG in 1.91 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2628924 | tezepelumab-ekko 110 MG/ML Auto-Injector [Tezspire] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2628924 | tezepelumab-ekko 110 MG/ML Auto-Injector [Tezspire] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2628925 | calcium carbonate 975 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2628926 | calcium carbonate 975 MG / magnesium carbonate 232 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628926 | calcium carbonate 975 MG / magnesium carbonate 232 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2628927 | Isospire | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2628928 | isoflurane 999 MG/ML [Isospire] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2628929 | Isospire Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2628930 | isoflurane Inhalation Solution [Isospire] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2628931 | Isospire 99.9 % Inhalation Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2628931 | Isospire 99.9 % Inhalation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2628931 | Isospire 99.9 % Inhalation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 26290 | guaiazulene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2629307 | Flexira | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2629308 | firocoxib 227 MG [Flexira] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2629309 | Flexira Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2629310 | Flexira Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2629311 | Flexira Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2629312 | firocoxib Chewable Tablet [Flexira] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2629313 | Flexira 227 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2629313 | Flexira 227 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2629313 | Flexira 227 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2629314 | firocoxib 57 MG [Flexira] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2629315 | Flexira 57 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2629315 | Flexira 57 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2629315 | Flexira 57 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2629337 | fentaNYL citrate 25 MCG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2629337 | fentaNYL citrate 25 MCG in 0.5 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2629337 | fentaNYL citrate 25 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2629337 | fentaNYL citrate 25 MCG in 0.5 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2629337 | fentaNYL citrate 25 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2629337 | fentaNYL citrate 25 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2629337 | fentaNYL citrate 25 MCG in 0.5 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2629338 | pirtobrutinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2629339 | pirtobrutinib 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2629340 | pirtobrutinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2629341 | pirtobrutinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2629342 | pirtobrutinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2629343 | pirtobrutinib 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2629343 | pirtobrutinib 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2629344 | Jaypirca | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2629345 | pirtobrutinib 100 MG [Jaypirca] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2629346 | Jaypirca Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2629347 | Jaypirca Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2629348 | pirtobrutinib Oral Tablet [Jaypirca] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2629349 | Jaypirca 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2629349 | Jaypirca 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2629349 | Jaypirca 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2629350 | pirtobrutinib 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2629351 | pirtobrutinib 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2629351 | pirtobrutinib 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2629352 | pirtobrutinib 50 MG [Jaypirca] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2629353 | Jaypirca 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2629353 | Jaypirca 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2629353 | Jaypirca 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 26296 | guanadrel | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 26296 | guanadrel | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 26296 | guanadrel | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 26296 | guanadrel | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 26296 | guanadrel | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2629641 | lithium oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2629642 | magnesium bromate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2629643 | triolein, 1-C-14 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2629680 | C-peptide | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2629680 | C-peptide | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2629718 | Pinus halepensis resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2629720 | Soluprep | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2629721 | chlorhexidine gluconate 20 MG/ML / isopropyl alcohol 0.7 ML/ML [Soluprep] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2629722 | Soluprep Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2629723 | chlorhexidine / isopropyl alcohol Topical Solution [Soluprep] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2629724 | SoluPrep 2 % / 70 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2629724 | SoluPrep 2 % / 70 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2629724 | SoluPrep 2 % / 70 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2629781 | Hedychium spicatum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2629818 | calamine 190 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2629819 | calamine 19 % / zinc oxide 19 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2629819 | calamine 19 % / zinc oxide 19 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2629819 | calamine 19 % / zinc oxide 19 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2629819 | calamine 19 % / zinc oxide 19 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2629820 | calamine 15 % / zinc oxide 5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2629820 | calamine 15 % / zinc oxide 5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2629820 | calamine 15 % / zinc oxide 5 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2629820 | calamine 15 % / zinc oxide 5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2629973 | dextromethorphan hydrobromide 20 MG / doxylamine succinate 12.5 MG in 20 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2629973 | dextromethorphan hydrobromide 20 MG / doxylamine succinate 12.5 MG in 20 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2629973 | dextromethorphan hydrobromide 20 MG / doxylamine succinate 12.5 MG in 20 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2629974 | Dectogard | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2629975 | doramectin 5 MG/ML [Dectogard] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2629976 | Dectogard Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2629977 | doramectin Topical Solution [Dectogard] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2629978 | Dectogard Pour-On 0.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2629978 | Dectogard Pour-On 0.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2629978 | Dectogard Pour-On 0.5 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2629979 | benzalkonium chloride 0.13 % / lidocaine 4 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2629979 | benzalkonium chloride 0.13 % / lidocaine 4 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2629979 | benzalkonium chloride 0.13 % / lidocaine 4 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2629980 | lanadelumab-flyo 150 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2629980 | lanadelumab-flyo 150 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2629980 | lanadelumab-flyo 150 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2629981 | Takhzyro 150 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2629981 | Takhzyro 150 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2629981 | Takhzyro 150 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2629982 | camphor / menthol / methyl salicylate Topical Foam | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2629983 | camphor 3 % / menthol 8 % / methyl salicylate 15 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2629983 | camphor 3 % / menthol 8 % / methyl salicylate 15 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2629983 | camphor 3 % / menthol 8 % / methyl salicylate 15 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2629984 | camphor 3 % / menthol 8 % / methyl salicylate 10 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2629984 | camphor 3 % / menthol 8 % / methyl salicylate 10 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2629984 | camphor 3 % / menthol 8 % / methyl salicylate 10 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2629985 | camphor 11 % / menthol 16 % / methyl salicylate 25 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2629985 | camphor 11 % / menthol 16 % / methyl salicylate 25 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2629985 | camphor 11 % / menthol 16 % / methyl salicylate 25 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |